false 2020 Q1 0001385280 --12-31 Large Accelerated Filer 0.3333 0.6666 P2Y 0.3333 0.6666 P3Y P1Y P1Y P1Y P1Y P1Y P1Y P1Y P1Y P1Y P1Y 0 0 0001385280 2020-01-01 2020-03-31 xbrli:shares 0001385280 2020-05-15 iso4217:USD 0001385280 2020-03-31 0001385280 2019-12-31 0001385280 cnk:NcmMember 2020-03-31 0001385280 cnk:NcmMember 2019-12-31 iso4217:USD xbrli:shares 0001385280 cnk:AdmissionsRevenueMember 2020-01-01 2020-03-31 0001385280 cnk:AdmissionsRevenueMember 2019-01-01 2019-03-31 0001385280 us-gaap:ConcessionsMember 2020-01-01 2020-03-31 0001385280 us-gaap:ConcessionsMember 2019-01-01 2019-03-31 0001385280 cnk:OtherRevenuesMember 2020-01-01 2020-03-31 0001385280 cnk:OtherRevenuesMember 2019-01-01 2019-03-31 0001385280 2019-01-01 2019-03-31 0001385280 cnk:NcmMember 2020-01-01 2020-03-31 0001385280 cnk:NcmMember 2019-01-01 2019-03-31 0001385280 2018-12-31 0001385280 2019-03-31 0001385280 cnk:NCMScreenAdvertisingAdvancesMember 2020-01-01 2020-03-31 0001385280 cnk:DigitalCinemaImplementationPartnersMember 2020-01-01 2020-03-31 0001385280 us-gaap:RestrictedStockMember 2020-01-01 2020-03-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-03-31 xbrli:pure 0001385280 srt:MinimumMember 2020-03-31 0001385280 srt:MaximumMember 2020-03-31 0001385280 us-gaap:NaturalDisastersAndOtherCasualtyEventsMember cnk:DirectorAndChiefExecutiveOfficerMember 2020-01-01 2020-03-31 0001385280 us-gaap:NaturalDisastersAndOtherCasualtyEventsMember 2020-01-01 2020-03-31 cnk:Employee 0001385280 us-gaap:NaturalDisastersAndOtherCasualtyEventsMember cnk:DomesticHourlyTheatreEmployeesMember 2020-01-01 2020-03-31 0001385280 us-gaap:NaturalDisastersAndOtherCasualtyEventsMember cnk:CoronavirusAidReliefAndEconomicSecurityActMember 2020-03-31 0001385280 cnk:UtilitiesAndOtherMember us-gaap:EquipmentMember 2020-01-01 2020-03-31 0001385280 cnk:UtilitiesAndOtherMember us-gaap:EquipmentMember 2019-01-01 2019-03-31 0001385280 cnk:FacilityLeasingExpenseMember cnk:RealEstatePropertyMember 2020-01-01 2020-03-31 0001385280 cnk:FacilityLeasingExpenseMember cnk:RealEstatePropertyMember 2019-01-01 2019-03-31 0001385280 cnk:DepreciationAndAmortizationMember 2020-01-01 2020-03-31 0001385280 cnk:DepreciationAndAmortizationMember 2019-01-01 2019-03-31 0001385280 us-gaap:InterestExpenseMember 2020-01-01 2020-03-31 0001385280 us-gaap:InterestExpenseMember 2019-01-01 2019-03-31 0001385280 cnk:RealEstatePropertyMember 2020-01-01 2020-03-31 0001385280 us-gaap:EquipmentMember 2020-01-01 2020-03-31 0001385280 us-gaap:EquipmentMember 2019-01-01 2019-03-31 0001385280 cnk:TheatresMember 2020-03-31 cnk:Agreement 0001385280 us-gaap:EquipmentMember 2020-03-31 0001385280 cnk:UsOperatingSegmentMember us-gaap:AdmissionMember 2020-01-01 2020-03-31 0001385280 cnk:InternationalOperatingSegmentMember us-gaap:AdmissionMember 2020-01-01 2020-03-31 0001385280 us-gaap:AdmissionMember 2020-01-01 2020-03-31 0001385280 cnk:UsOperatingSegmentMember us-gaap:ConcessionsMember 2020-01-01 2020-03-31 0001385280 cnk:InternationalOperatingSegmentMember us-gaap:ConcessionsMember 2020-01-01 2020-03-31 0001385280 cnk:UsOperatingSegmentMember cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember 2020-01-01 2020-03-31 0001385280 cnk:InternationalOperatingSegmentMember cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember 2020-01-01 2020-03-31 0001385280 cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember 2020-01-01 2020-03-31 0001385280 cnk:UsOperatingSegmentMember cnk:OtherRevenueMember 2020-01-01 2020-03-31 0001385280 cnk:InternationalOperatingSegmentMember cnk:OtherRevenueMember 2020-01-01 2020-03-31 0001385280 cnk:OtherRevenueMember 2020-01-01 2020-03-31 0001385280 cnk:UsOperatingSegmentMember 2020-01-01 2020-03-31 0001385280 cnk:InternationalOperatingSegmentMember 2020-01-01 2020-03-31 0001385280 us-gaap:AdmissionMember cnk:UsOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 us-gaap:AdmissionMember cnk:InternationalOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 us-gaap:AdmissionMember 2019-01-01 2019-03-31 0001385280 us-gaap:ConcessionsMember cnk:UsOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 us-gaap:ConcessionsMember cnk:InternationalOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember cnk:UsOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember cnk:InternationalOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember 2019-01-01 2019-03-31 0001385280 cnk:OtherRevenueMember cnk:UsOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 cnk:OtherRevenueMember cnk:InternationalOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 cnk:OtherRevenueMember 2019-01-01 2019-03-31 0001385280 cnk:UsOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 cnk:InternationalOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 us-gaap:TransferredAtPointInTimeMember cnk:UsOperatingSegmentMember 2020-01-01 2020-03-31 0001385280 us-gaap:TransferredAtPointInTimeMember cnk:InternationalOperatingSegmentMember 2020-01-01 2020-03-31 0001385280 us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-03-31 0001385280 us-gaap:TransferredOverTimeMember cnk:UsOperatingSegmentMember 2020-01-01 2020-03-31 0001385280 us-gaap:TransferredOverTimeMember cnk:InternationalOperatingSegmentMember 2020-01-01 2020-03-31 0001385280 us-gaap:TransferredOverTimeMember 2020-01-01 2020-03-31 0001385280 us-gaap:TransferredAtPointInTimeMember cnk:UsOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 us-gaap:TransferredAtPointInTimeMember cnk:InternationalOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 us-gaap:TransferredAtPointInTimeMember 2019-01-01 2019-03-31 0001385280 us-gaap:TransferredOverTimeMember cnk:UsOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 us-gaap:TransferredOverTimeMember cnk:InternationalOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 us-gaap:TransferredOverTimeMember 2019-01-01 2019-03-31 0001385280 cnk:NCMScreenAdvertisingAdvancesMember 2019-12-31 0001385280 cnk:OtherDeferredRevenuesMember 2019-12-31 0001385280 cnk:OtherDeferredRevenuesMember 2020-01-01 2020-03-31 0001385280 cnk:NCMScreenAdvertisingAdvancesMember cnk:NcmMember 2020-01-01 2020-03-31 0001385280 cnk:NCMScreenAdvertisingAdvancesMember 2020-03-31 0001385280 cnk:OtherDeferredRevenuesMember 2020-03-31 0001385280 2020-04-01 2020-03-31 0001385280 2021-04-01 2020-03-31 0001385280 2022-04-01 2020-03-31 0001385280 2023-04-01 2020-03-31 0001385280 2024-04-01 2020-03-31 0001385280 2025-04-01 2020-03-31 0001385280 cnk:OtherDeferredRevenuesMember 2020-04-01 2020-03-31 0001385280 cnk:OtherDeferredRevenuesMember 2021-04-01 2020-03-31 0001385280 cnk:OtherDeferredRevenuesMember 2022-04-01 2020-03-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-03-31 0001385280 cnk:TermLoanCreditFacilityMember cnk:SeniorSecuredCreditFacilityMember 2020-03-31 0001385280 cnk:RevolvingCreditLineMember cnk:SeniorSecuredCreditFacilityMember 2020-03-31 0001385280 cnk:RevolvingCreditLineMember cnk:SeniorSecuredCreditFacilityMember 2020-03-25 2020-03-25 0001385280 cnk:SeniorSecuredCreditFacilityMember 2020-03-31 0001385280 cnk:SeniorSecuredCreditFacilityMember 2020-01-01 2020-03-31 0001385280 cnk:SeniorSecuredCreditFacilityMember cnk:TermLoanCreditFacilityMember 2020-01-01 2020-03-31 0001385280 cnk:SeniorSecuredCreditFacilityMember cnk:RevolvingCreditLineMember 2020-01-01 2020-03-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementOneMember 2020-03-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementTwoMember 2020-03-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementThreeMember 2020-03-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementFourMember 2020-03-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementOneMember 2020-01-01 2020-03-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementTwoMember 2020-01-01 2020-03-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementThreeMember 2020-01-01 2020-03-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementFourMember 2020-01-01 2020-03-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2020-03-31 0001385280 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2020-03-31 0001385280 us-gaap:OtherNoncurrentLiabilitiesMember 2020-03-31 0001385280 us-gaap:InterestRateSwapMember 2020-03-31 0001385280 us-gaap:CommonStockMember 2019-12-31 0001385280 us-gaap:TreasuryStockMember 2019-12-31 0001385280 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001385280 us-gaap:RetainedEarningsMember 2019-12-31 0001385280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001385280 us-gaap:ParentMember 2019-12-31 0001385280 us-gaap:NoncontrollingInterestMember 2019-12-31 0001385280 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001385280 us-gaap:ParentMember 2020-01-01 2020-03-31 0001385280 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0001385280 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001385280 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0001385280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001385280 us-gaap:CommonStockMember 2020-03-31 0001385280 us-gaap:TreasuryStockMember 2020-03-31 0001385280 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001385280 us-gaap:RetainedEarningsMember 2020-03-31 0001385280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001385280 us-gaap:ParentMember 2020-03-31 0001385280 us-gaap:NoncontrollingInterestMember 2020-03-31 0001385280 us-gaap:CommonStockMember 2018-12-31 0001385280 us-gaap:TreasuryStockMember 2018-12-31 0001385280 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001385280 us-gaap:RetainedEarningsMember 2018-12-31 0001385280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001385280 us-gaap:ParentMember 2018-12-31 0001385280 us-gaap:NoncontrollingInterestMember 2018-12-31 0001385280 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001385280 us-gaap:ParentMember 2019-01-01 2019-03-31 0001385280 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001385280 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0001385280 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-03-31 0001385280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001385280 us-gaap:CommonStockMember 2019-03-31 0001385280 us-gaap:TreasuryStockMember 2019-03-31 0001385280 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001385280 us-gaap:RetainedEarningsMember 2019-03-31 0001385280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001385280 us-gaap:ParentMember 2019-03-31 0001385280 us-gaap:NoncontrollingInterestMember 2019-03-31 0001385280 cnk:InvestmentInNcmMember 2019-12-31 0001385280 cnk:InvestmentInNcmMember 2020-01-01 2020-03-31 0001385280 cnk:OtherRevenueMember 2020-01-01 2020-03-31 0001385280 cnk:CashReceivedMember 2020-01-01 2020-03-31 0001385280 cnk:InterestExpenseNcmMember 2020-01-01 2020-03-31 0001385280 cnk:DistributionsFromNcmMember 2020-01-01 2020-03-31 0001385280 cnk:EquityEarningsMember cnk:NcmMember 2020-01-01 2020-03-31 0001385280 cnk:OtherRevenueMember cnk:NcmMember 2020-01-01 2020-03-31 0001385280 cnk:InvestmentInNcmMember 2020-03-31 0001385280 cnk:DistributionsFromNcmMember 2020-03-31 0001385280 cnk:EquityEarningsMember 2020-03-31 0001385280 cnk:OtherRevenueMember 2020-03-31 0001385280 cnk:InterestExpenseNcmMember 2020-03-31 0001385280 cnk:CashReceivedMember 2020-03-31 0001385280 2021-01-01 cnk:NCMScreenAdvertisingAdvancesMember 2020-03-31 0001385280 2022-01-01 cnk:NCMScreenAdvertisingAdvancesMember 2020-03-31 0001385280 2023-01-01 cnk:NCMScreenAdvertisingAdvancesMember 2020-03-31 0001385280 2024-01-01 cnk:NCMScreenAdvertisingAdvancesMember 2020-03-31 0001385280 2025-01-01 cnk:NCMScreenAdvertisingAdvancesMember 2020-03-31 0001385280 2026-01-01 cnk:NCMScreenAdvertisingAdvancesMember 2020-03-31 0001385280 cnk:NcmMember srt:MinimumMember 2020-01-01 2020-03-31 0001385280 cnk:NcmMember srt:MaximumMember 2020-01-01 2020-03-31 0001385280 cnk:NcmMember 2019-12-27 2020-03-26 0001385280 cnk:NcmMember 2018-12-28 2019-03-28 0001385280 cnk:NcmMember 2020-03-26 0001385280 cnk:NcmMember 2019-12-26 0001385280 cnk:DigitalCinemaImplementationPartnersMember us-gaap:OtherAffiliatesMember 2019-12-31 0001385280 cnk:ACJVLLCMember us-gaap:OtherAffiliatesMember 2019-12-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember us-gaap:OtherAffiliatesMember 2019-12-31 0001385280 cnk:FEConceptsLLCMember us-gaap:OtherAffiliatesMember 2019-12-31 0001385280 cnk:OtherInvestmentMember us-gaap:OtherAffiliatesMember 2019-12-31 0001385280 us-gaap:OtherAffiliatesMember 2019-12-31 0001385280 cnk:DigitalCinemaImplementationPartnersMember us-gaap:OtherAffiliatesMember 2020-01-01 2020-03-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember us-gaap:OtherAffiliatesMember 2020-01-01 2020-03-31 0001385280 us-gaap:OtherAffiliatesMember 2020-01-01 2020-03-31 0001385280 cnk:ACJVLLCMember us-gaap:OtherAffiliatesMember 2020-01-01 2020-03-31 0001385280 cnk:FEConceptsLLCMember us-gaap:OtherAffiliatesMember 2020-01-01 2020-03-31 0001385280 cnk:OtherInvestmentMember us-gaap:OtherAffiliatesMember 2020-01-01 2020-03-31 0001385280 cnk:DigitalCinemaImplementationPartnersMember us-gaap:OtherAffiliatesMember 2020-03-31 0001385280 cnk:ACJVLLCMember us-gaap:OtherAffiliatesMember 2020-03-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember us-gaap:OtherAffiliatesMember 2020-03-31 0001385280 cnk:FEConceptsLLCMember us-gaap:OtherAffiliatesMember 2020-03-31 0001385280 cnk:OtherInvestmentMember us-gaap:OtherAffiliatesMember 2020-03-31 0001385280 us-gaap:OtherAffiliatesMember 2020-03-31 0001385280 cnk:DigitalCinemaImplementationPartnersMember 2020-03-31 0001385280 cnk:DigitalCinemaImplementationPartnersMember srt:MaximumMember 2020-01-01 2020-03-31 cnk:Studio 0001385280 us-gaap:OtherAffiliatesMember cnk:DigitalCinemaImplementationPartnersMember 2019-01-01 2019-03-31 cnk:ProjectionSystem 0001385280 cnk:DigitalCinemaImplementationPartnersMember 2019-01-01 2019-03-31 0001385280 cnk:FilmRentalsAndAdvertisingMember cnk:ACJVLLCMember 2020-01-01 2020-03-31 0001385280 cnk:FilmRentalsAndAdvertisingMember cnk:ACJVLLCMember 2019-01-01 2019-03-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember 2020-03-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember 2020-01-01 2020-03-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember 2019-01-01 2019-03-31 0001385280 cnk:CNMKTexasPropertiesLLCMember 2018-04-29 2018-04-30 0001385280 cnk:CNMKTexasPropertiesLLCMember cnk:AWSRInvestmentsLimitedLiabilityCompanyMember 2018-04-29 2018-04-30 0001385280 cnk:CNMKTexasPropertiesLLCMember 2018-04-30 0001385280 cnk:CNMKTexasPropertiesLLCMember cnk:AWSRInvestmentsLimitedLiabilityCompanyMember 2018-04-30 0001385280 cnk:CNMKTexasPropertiesLLCMember cnk:AWSRInvestmentsLimitedLiabilityCompanyMember cnk:TheatreServicesMember 2020-01-01 2020-03-31 0001385280 srt:MinimumMember 2020-01-01 2020-03-31 0001385280 srt:MaximumMember 2020-01-01 2020-03-31 0001385280 us-gaap:RestrictedStockMember srt:MinimumMember 2020-01-01 2020-03-31 0001385280 us-gaap:RestrictedStockMember srt:MaximumMember 2020-01-01 2020-03-31 0001385280 us-gaap:RestrictedStockMember 2019-12-31 0001385280 us-gaap:RestrictedStockMember 2020-03-31 0001385280 us-gaap:RestrictedStockMember 2019-01-01 2019-03-31 0001385280 cnk:UnvestedRestrictedStockAwardsMember 2020-03-31 0001385280 cnk:UnvestedRestrictedStockAwardsMember 2020-01-01 2020-03-31 0001385280 cnk:ThresholdIrrMember srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-03-31 0001385280 cnk:TargetedIrrMember srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-03-31 0001385280 cnk:MaximumIrrMember srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-03-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember 2020-03-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember cnk:StockGrantsTwentySeventeenMember 2020-01-01 2020-03-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember cnk:StockGrantsTwentyEightteenMember 2020-01-01 2020-03-31 0001385280 cnk:UsOperatingSegmentMember 2019-12-31 0001385280 cnk:InternationalOperatingSegmentMember 2019-12-31 0001385280 cnk:UsOperatingSegmentMember 2020-03-31 0001385280 cnk:InternationalOperatingSegmentMember 2020-03-31 cnk:Community cnk:Country cnk:Unit 0001385280 us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001385280 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001385280 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001385280 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001385280 country:BR 2020-03-31 0001385280 country:CL 2020-03-31 0001385280 stpr:CO 2020-03-31 0001385280 country:PE 2020-03-31 0001385280 country:BR 2019-12-31 0001385280 country:CL 2019-12-31 0001385280 stpr:CO 2019-12-31 0001385280 country:PE 2019-12-31 0001385280 country:BR 2020-01-01 2020-03-31 0001385280 country:CL 2020-01-01 2020-03-31 0001385280 stpr:CO 2020-01-01 2020-03-31 0001385280 country:PE 2020-01-01 2020-03-31 0001385280 cnk:OtherForeignCountriesMember 2020-01-01 2020-03-31 0001385280 cnk:InternationalSubsidiariesMember us-gaap:ParentMember 2020-01-01 2020-03-31 0001385280 country:BR 2019-01-01 2019-03-31 0001385280 country:CL 2019-01-01 2019-03-31 0001385280 stpr:CO 2019-01-01 2019-03-31 0001385280 country:PE 2019-01-01 2019-03-31 0001385280 cnk:OtherForeignCountriesMember 2019-01-01 2019-03-31 0001385280 cnk:InternationalSubsidiariesMember us-gaap:ParentMember 2019-01-01 2019-03-31 0001385280 country:AR 2020-01-01 2020-03-31 0001385280 country:AR 2019-01-01 2019-03-31 0001385280 2019-01-01 2019-12-31 0001385280 us-gaap:OperatingSegmentsMember cnk:UsOperatingSegmentMember 2020-01-01 2020-03-31 0001385280 us-gaap:OperatingSegmentsMember cnk:UsOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 us-gaap:OperatingSegmentsMember cnk:InternationalOperatingSegmentMember 2020-01-01 2020-03-31 0001385280 us-gaap:OperatingSegmentsMember cnk:InternationalOperatingSegmentMember 2019-01-01 2019-03-31 0001385280 us-gaap:IntersegmentEliminationMember 2020-01-01 2020-03-31 0001385280 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-03-31 0001385280 cnk:OtherInvesteesMember 2020-01-01 2020-03-31 0001385280 cnk:OtherInvesteesMember 2019-01-01 2019-03-31 0001385280 srt:ReportableGeographicalComponentsMember country:US 2020-01-01 2020-03-31 0001385280 srt:ReportableGeographicalComponentsMember country:US 2019-01-01 2019-03-31 0001385280 srt:ReportableGeographicalComponentsMember country:BR 2020-01-01 2020-03-31 0001385280 srt:ReportableGeographicalComponentsMember country:BR 2019-01-01 2019-03-31 0001385280 srt:ReportableGeographicalComponentsMember cnk:OtherInternationalCountriesMember 2020-01-01 2020-03-31 0001385280 srt:ReportableGeographicalComponentsMember cnk:OtherInternationalCountriesMember 2019-01-01 2019-03-31 0001385280 srt:GeographyEliminationsMember 2020-01-01 2020-03-31 0001385280 srt:GeographyEliminationsMember 2019-01-01 2019-03-31 0001385280 country:US srt:ReportableGeographicalComponentsMember 2020-03-31 0001385280 country:US srt:ReportableGeographicalComponentsMember 2019-12-31 0001385280 country:BR srt:ReportableGeographicalComponentsMember 2020-03-31 0001385280 country:BR srt:ReportableGeographicalComponentsMember 2019-12-31 0001385280 cnk:OtherInternationalCountriesMember srt:ReportableGeographicalComponentsMember 2020-03-31 0001385280 cnk:OtherInternationalCountriesMember srt:ReportableGeographicalComponentsMember 2019-12-31 0001385280 cnk:LaredoTheatreLtdMember 2020-01-01 2020-03-31 0001385280 cnk:LaredoTheatreLtdMember 2019-01-01 2019-03-31 0001385280 cnk:CopperBeechCapitalLLCMember 2020-01-01 2020-03-31 0001385280 cnk:CopperBeechCapitalLLCMember 2019-01-01 2019-03-31 cnk:Theatre 0001385280 cnk:SyufyEnterprisesLpMember 2020-01-01 2020-03-31 cnk:Facility cnk:Lease 0001385280 cnk:SyufyEnterprisesLpMember 2019-01-01 2019-03-31 0001385280 cnk:FEConceptsLLCMember 2020-03-31 0001385280 cnk:FEConceptsLLCMember 2020-01-01 2020-03-31 0001385280 cnk:EightPointSevenFivePercentSecuredNotesMember us-gaap:SubsequentEventMember 2020-04-20 0001385280 cnk:EightPointSevenFivePercentSecuredNotesMember us-gaap:SubsequentEventMember 2020-04-20 2020-04-20 0001385280 cnk:FivePointOneTwoFivePercentSeniorNoteMember srt:ScenarioForecastMember 2022-09-13 0001385280 cnk:FivePointOneTwoFivePercentSeniorNoteMember srt:ScenarioForecastMember 2022-09-13 2022-09-13 0001385280 cnk:FourPointEightSevenFivePercentSeniorNotesMember srt:ScenarioForecastMember 2023-02-27 0001385280 cnk:FourPointEightSevenFivePercentSeniorNotesMember srt:ScenarioForecastMember 2023-02-27 2023-02-27

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2020

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 001-33401

CINEMARK HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

20-5490327

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

 

 

3900 Dallas Parkway

 

 

Plano, Texas

 

75093

(Address of principal executive offices)

 

(Zip Code)

Registrant's telephone number, including area code:  (972) 665-1000

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, par value $.001 per share

CNK

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit files).    Yes   No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

  

Accelerated filer

 

 

 

 

 

 

 

 

Non-accelerated filer

 

  

Smaller reporting company

 

 

 

 

 

 

 

 

Emerging growth company

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes   No 

As of May 15, 2020, 117,589,645 shares of common stock were issued and outstanding.  

 

 


 

EXPLANATORY NOTE

 

Cinemark Holdings, Inc. (the “Company”, “we,” or “us”), is filing this Form 10-Q for the period ended March 31, 2020 after the May 11, 2020 deadline in reliance on the 45-day extension provided by the Securities and Exchange Commission (the “SEC”) Order Under Section 36 of the Securities Exchange Act of 1934 (the “Exchange Act”) Modifying Exemptions from the Reporting and Proxy Delivery Requirements for Public Companies (Release No. 34-88465), dated March 25, 2020 (the “Order”).  The COVID-19 pandemic has had an unprecedented impact on our business and operations including the furlough of 50% of our headquarter employees, reduction in work hours of the remaining employees due to a 50% pay reduction and temporary closure of our corporate headquarters due to our work from home policy issued for the safety of our employees and their families, following protective actions taken by state and local governments.  Due to these operational challenges, we could not file this Form 10-Q within the time period specified under the Exchange Act.

 

Pursuant to the requirements of the Order, we filed a Form 8-K with the SEC on May 8, 2020 indicating our intention to rely upon the Order with respect to the filing of this Form 10-Q which is being filed within the 45-day extension period provided by the Order.

 

 

 

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

 

 

 

 

 

Page

PART I.     FINANCIAL INFORMATION

 

 

 

 

 

 

 

 

Item 1.

Financial Statements

 

4

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets as of March 31, 2020 and December 31, 2019 (unaudited)

 

4

 

 

 

 

 

 

 

Condensed Consolidated Statements of Income (Loss) for the three months ended March 31, 2020 and 2019 (unaudited)

 

5

 

 

 

 

 

 

 

Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2020 and 2019 (unaudited)

 

6

 

 

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2020 and 2019 (unaudited)

 

7

 

 

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements (unaudited)

 

8

 

 

 

 

 

 

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

 

30

 

 

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

40

 

 

 

 

 

 

Item 4.

Controls and Procedures

 

40

 

 

 

 

 

PART II.     OTHER INFORMATION

 

 

 

 

 

 

 

 

Item 1.

Legal Proceedings

 

41

 

 

 

 

 

 

Item 1A.

Risk Factors

 

41

 

 

 

 

 

 

Item 6.

Exhibits

 

42

 

 

 

 

 

SIGNATURES

 

43

 

2


 

Cautionary Statement Regarding Forward-Looking Statements

Certain matters within this Quarterly Report on Form 10Q include “forward–looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The “forward-looking statements” may include our current expectations, assumptions, estimates and projections about our business and our industry. They may include statements relating to future revenues, expenses and profitability, the future development and expected growth of our business, projected capital expenditures, attendance at movies generally or in any of the markets in which we operate, the number or diversity of popular movies released and our ability to successfully license and exhibit popular films, national and international growth in our industry, competition from other exhibitors and alternative forms of entertainment and determinations in lawsuits in which we are defendants.  Forward-looking statements can be identified by the use of words such as “may,” “should,” “could,” “estimates,” “predicts,” “potential,” “continue,” “anticipates,” “believes,” “plans,” “expects,” “future” and “intends” and similar expressions. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results or performance to differ from those projected in the forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict, including, among others, the impacts of COVID-19.  Such risks and uncertainties could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.  For a description of the risk factors, please review the “Risk Factors” section or other sections in the Company’s Annual Report on Form 10-K filed February 21, 2020, as updated by the information related to COVID-19 that was included in a Form 8-K that was filed on April 13, 2020, including the documents incorporated by reference therein. All forward-looking statements are expressly qualified in their entirety by such risk factors. We undertake no obligation, other than as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

3


 

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data, unaudited)

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Assets

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

479,399

 

 

$

488,313

 

Inventories

 

 

17,972

 

 

 

21,686

 

Accounts receivable

 

 

51,641

 

 

 

83,722

 

Current income tax receivable

 

 

25,294

 

 

 

4,082

 

Prepaid expenses and other

 

 

13,361

 

 

 

37,187

 

Total current assets

 

 

587,667

 

 

 

634,990

 

 

 

 

 

 

 

 

 

 

Theatre properties and equipment

 

 

3,270,551

 

 

 

3,348,237

 

Less: accumulated depreciation and amortization

 

 

1,612,226

 

 

 

1,612,990

 

Theatre properties and equipment, net

 

 

1,658,325

 

 

 

1,735,247

 

 

 

 

 

 

 

 

 

 

Operating lease right-of-use assets, net

 

 

1,338,069

 

 

 

1,383,080

 

 

 

 

 

 

 

 

 

 

Other assets

 

 

 

 

 

 

 

 

Goodwill

 

 

1,268,559

 

 

 

1,283,371

 

Intangible assets, net

 

 

318,657

 

 

 

321,769

 

Investment in NCM

 

 

265,371

 

 

 

265,792

 

Investments in and advances to affiliates

 

 

151,232

 

 

 

155,285

 

Long-term deferred tax asset

 

 

8,851

 

 

 

9,369

 

Deferred charges and other assets, net

 

 

36,162

 

 

 

39,114

 

Total other assets

 

 

2,048,832

 

 

 

2,074,700

 

Total assets

 

$

5,632,893

 

 

$

5,828,017

 

 

 

 

 

 

 

 

 

 

Liabilities and equity

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Current portion of long-term debt

 

$

6,595

 

 

$

6,595

 

Current portion of operating lease obligations

 

 

213,941

 

 

 

217,406

 

Current portion of finance lease obligations

 

 

15,693

 

 

 

15,432

 

Current income tax payable

 

 

3,969

 

 

 

5,195

 

Current liability for uncertain tax positions

 

 

13,446

 

 

 

13,446

 

Accounts payable and accrued expenses

 

 

346,783

 

 

 

450,726

 

Total current liabilities

 

 

600,427

 

 

 

708,800

 

Long-term liabilities

 

 

 

 

 

 

 

 

Long-term debt, less current portion

 

 

1,869,821

 

 

 

1,771,342

 

Operating lease obligations, less current portion

 

 

1,186,416

 

 

 

1,223,462

 

Finance lease obligations, less current portion

 

 

136,967

 

 

 

141,017

 

Long-term deferred tax liability

 

 

157,918

 

 

 

141,836

 

Long-term liability for uncertain tax positions

 

 

939

 

 

 

848

 

NCM screen advertising advances

 

 

350,104

 

 

 

348,354

 

Other long-term liabilities

 

 

64,736

 

 

 

44,036

 

Total long-term liabilities

 

 

3,766,901

 

 

 

3,670,895

 

Commitments and contingencies (see Note 19)

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

Cinemark Holdings, Inc.'s stockholders' equity:

 

 

 

 

 

 

 

 

Common stock, $0.001 par value: 300,000,000 shares authorized, 122,328,781 shares issued and 117,518,721 shares outstanding at March 31, 2020 and 121,863,515 shares issued and 117,151,656 shares outstanding at December 31, 2019

 

 

122

 

 

 

122

 

Additional paid-in-capital

 

 

1,174,150

 

 

 

1,170,039

 

Treasury stock, 4,810,060 and 4,711,859 shares, at cost, at March 31, 2020 and December 31, 2019, respectively

 

 

(84,258

)

 

 

(81,567

)

Retained earnings

 

 

585,174

 

 

 

687,332

 

Accumulated other comprehensive loss

 

 

(421,908

)

 

 

(340,112

)

Total Cinemark Holdings, Inc.'s stockholders' equity

 

 

1,253,280

 

 

 

1,435,814

 

Noncontrolling interests

 

 

12,285

 

 

 

12,508

 

Total equity

 

 

1,265,565

 

 

 

1,448,322

 

Total liabilities and equity

 

$

5,632,893

 

 

$

5,828,017

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

4


 

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(in thousands, except per share data, unaudited)

 

 

 

 

Three Months Ended March 31,

 

 

 

 

2020

 

 

2019

 

Revenues

 

 

 

 

 

 

 

 

 

Admissions

 

 

$

292,462

 

 

$

395,540

 

Concession

 

 

 

190,356

 

 

 

251,324

 

Other

 

 

 

60,798

 

 

 

67,859

 

Total revenues

 

 

 

543,616

 

 

 

714,723

 

 

 

 

 

 

 

 

 

 

 

Cost of operations

 

 

 

 

 

 

 

 

 

Film rentals and advertising

 

 

 

156,617

 

 

 

210,077

 

Concession supplies

 

 

 

34,812

 

 

 

43,071

 

Salaries and wages

 

 

 

87,544

 

 

 

96,136

 

Facility lease expense

 

 

 

82,241

 

 

 

85,613

 

Utilities and other

 

 

 

100,523

 

 

 

110,637

 

General and administrative expenses

 

 

 

41,018

 

 

 

37,976

 

Depreciation and amortization

 

 

 

65,256

 

 

 

64,462

 

Impairment of long-lived assets

 

 

 

16,619

 

 

 

5,584

 

Loss on disposal of assets and other

 

 

 

1,905

 

 

 

3,799

 

Total cost of operations

 

 

 

586,535

 

 

 

657,355

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

 

 

(42,919

)

 

 

57,368

 

 

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

 

 

Interest expense

 

 

 

(24,666

)

 

 

(25,141

)

Interest income

 

 

 

2,084

 

 

 

2,691

 

Foreign currency exchange gain (loss)

 

 

 

(4,848

)

 

 

22

 

Distributions from NCM

 

 

 

5,224

 

 

 

4,548

 

Interest expense - NCM

 

 

 

(5,891

)

 

 

(4,782

)

Equity in income of affiliates

 

 

 

8,486

 

 

 

10,404

 

Total other expense

 

 

 

(19,611

)

 

 

(12,258

)

 

 

 

 

 

 

 

 

 

 

Income (loss) before income taxes

 

 

 

(62,530

)

 

 

45,110

 

Income taxes

 

 

 

(3,108

)

 

 

11,917

 

Net income (loss)

 

 

$

(59,422

)

 

$

33,193

 

Less:  Net income attributable to noncontrolling interests

 

 

 

169

 

 

 

465

 

Net income (loss) attributable to Cinemark Holdings, Inc.

 

 

$

(59,591

)

 

$

32,728

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

 

116,496

 

 

 

116,179

 

Diluted

 

 

 

116,496

 

 

 

116,418

 

 

 

 

 

 

 

 

 

 

 

Earnings (loss) per share attributable to Cinemark Holdings, Inc.'s common stockholders

 

 

 

 

 

 

 

 

 

Basic

 

 

$

(0.51

)

 

$

0.28

 

Diluted

 

 

$

(0.51

)

 

$

0.28

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

5


 

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In thousands, unaudited)

 

 

 

 

Three Months Ended March 31,

 

 

 

 

2020

 

 

2019

 

Net income (loss)

 

 

$

(59,422

)

 

$

33,193

 

Other comprehensive income (loss), net of tax

 

 

 

 

 

 

 

 

 

Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $2,230 and $1,069, net of settlements

 

 

 

(24,171

)

 

 

(3,311

)

Other comprehensive loss in equity method investments

 

 

 

 

 

 

(71

)

Foreign currency translation adjustments

 

 

 

(57,625

)

 

 

755

 

Total other comprehensive loss, net of tax

 

 

 

(81,796

)

 

 

(2,627

)

Total comprehensive income (loss), net of tax

 

 

 

(141,218

)

 

 

30,566

 

Comprehensive income attributable to noncontrolling interests

 

 

 

(169

)

 

 

(465

)

Comprehensive income (loss) attributable to Cinemark Holdings, Inc.

 

 

$

(141,387

)

 

$

30,101

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

6


 

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands, unaudited)

 

 

 

Three Months Ended March 31,

 

 

 

2020

 

 

2019

 

Operating activities

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(59,422

)

 

$

33,193

 

Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:

 

 

 

 

 

 

 

 

Depreciation

 

 

64,005

 

 

 

63,247

 

Amortization of intangible and other assets

 

 

1,251

 

 

 

1,215

 

Amortization of debt issue costs

 

 

1,328

 

 

 

1,328

 

Amortization of NCM screen advertising advances and other deferred revenues

 

 

(7,852

)

 

 

(4,021

)

Interest accrued on NCM screen advertising advances

 

 

5,891

 

 

 

 

Impairment of long-lived assets

 

 

16,619

 

 

 

5,584

 

Share based awards compensation expense

 

 

4,111

 

 

 

2,970

 

Loss on disposal of assets and other

 

 

1,905

 

 

 

3,799

 

Non-cash rent expense

 

 

(591

)

 

 

(819

)

Equity in income of affiliates

 

 

(8,486

)

 

 

(10,404

)

Deferred income tax expenses

 

 

15,364

 

 

 

(10,964

)

Distributions from equity investees

 

 

16,606

 

 

 

14,342

 

Changes in assets and liabilities and other

 

 

(66,290

)

 

 

4,814

 

Net cash provided by (used for) operating activities

 

 

(15,561

)

 

 

104,284

 

 

 

 

 

 

 

 

 

 

Investing activities

 

 

 

 

 

 

 

 

Additions to theatre properties and equipment

 

 

(34,143

)

 

 

(57,569

)

Proceeds from sale of theatre properties and equipment and other

 

 

55

 

 

 

57

 

Investment in joint ventures and other, net

 

 

(50

)

 

 

 

Net cash used for investing activities

 

 

(34,138

)

 

 

(57,512

)

 

 

 

 

 

 

 

 

 

Financing activities

 

 

 

 

 

 

 

 

Dividends paid to stockholders

 

 

(42,311

)

 

 

(39,797

)

Payroll taxes paid as a result of stock withholdings

 

 

(2,691

)

 

 

(1,947

)

Proceeds from revolving line of credit

 

 

98,800

 

 

 

 

Repayments of long-term debt

 

 

(1,649

)

 

 

(1,649

)

Payments on finance leases

 

 

(3,789

)

 

 

(3,517

)

Other

 

 

(392

)

 

 

(1,000

)

Net cash provided by (used for) financing activities

 

 

47,968

 

 

 

(47,910

)

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

 

(7,183

)

 

 

110

 

 

 

 

 

 

 

 

 

 

Decrease in cash and cash equivalents

 

 

(8,914

)

 

 

(1,028

)

 

 

 

 

 

 

 

 

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

Beginning of period

 

 

488,313

 

 

 

426,222

 

End of period

 

$

479,399

 

 

$

425,194

 

 

 

 

 

 

 

 

 

 

Supplemental information (see Note 16)

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

 

 

7


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

 

1.

The Company and Basis of Presentation

The Company and its subsidiaries operate in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay.

The accompanying condensed consolidated balance sheet as of December 31, 2019, which was derived from audited financial statements, and the unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from these estimates. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these subsidiaries and affiliates are included in the condensed consolidated financial statements effective with their formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation.  

These condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and the notes thereto for the year ended December 31, 2019, included in the Annual Report on Form 10-K filed February 21, 2020 by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Operating results for the three months ended March 31, 2020 are not necessarily indicative of the results to be achieved for the full year.

2.

Impact of COVID-19

The recent outbreak of the COVID-19 pandemic has had an unprecedented impact on the world and the movie exhibition industry. The situation continues to be volatile and the social and economic effects are widespread. As a movie exhibitor that operates spaces where patrons gather in close proximity, the Company’s business has been significantly impacted by protective actions that federal, state and local governments have taken to control the spread of the pandemic. These actions include, among other things, encouragement of social distancing, restrictions on freedom of movement, business closures, quarantines, and shelter-in-place and stay-at-home orders. As a result of these measures, the Company temporarily closed all of its theatres in the U.S. and Latin America effective March 18, 2020.

 

The Company believes it has sufficient cash to sustain its operations for the remainder of the year, even if its theatres remained closed for the remainder of the year.  Nonetheless, the COVID-19 pandemic has had and may continue to have adverse effects on the Company’s business, results of operations, cash flows and financial condition.  In light of the COVID-19 pandemic, the Company has been working to preserve cash and ensure sufficient liquidity to endure the impacts of the global crisis, even if prolonged.   Some of the recent actions taken by the Company include the following:

 

 

directors of the Company and its chief executive officer have elected to take no salary, and many of its executives have voluntarily reduced their salaries by 80% while the Company’s theatres remain closed;

 

halted all non-essential operating and capital expenditures, such as marketing promotions and initiatives, travel and entertainment, system enhancements and related consulting projects, recliner conversions, XD expansions and certain other theatre enhancements, which will significantly reduce utilities and other costs, general and administrative expenses and capital expenditures on a temporary basis;

 

suspended the quarterly dividend;

 

implemented a formal daily review and approval process by the Company’s chief financial officer for all outgoing procurement and payment requests;

 

laid off over 17,500 domestic hourly theatre employees, furloughed 50% of headquarter employees at 20% of salary (with full benefits) and reduced salaries of remaining employees by 50% and pursued similar actions in international markets to the extent permitted by local laws; which will significantly reduce salaries and wages expenses and general administrative expenses while theatres are closed; and

 

started working actively with landlords and major suppliers to modify the timing of certain contractual payments.

8


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

 

The Company continues to evaluate the impact of certain tax-related benefits available under the Coronavirus Aid, Relief, and Economic Security Act of 2020 (the “Cares Act”) signed into U.S. federal law on March 27, 2020. The Cares Act, among other things, includes provisions relating to refundable payroll tax credits, deferment of employer social security payments, net operating loss (“NOL”) utilization and carryback periods, modifications to the net interest deduction limitations and a technical correction to the 2017 Tax Cuts and Jobs Act, which makes certain qualified improvement property eligible for bonus depreciation.  Based upon a review of the Cares Act, the Company expects to:

 

 

receive an approximately $20,000 cash tax refund in 2020 related to qualified improvement property expenditures from 2018 and 2019;

 

benefit from the ability to defer social security payroll tax matches that would otherwise be required in 2020;

 

receive a payroll tax credit in 2020 for expenses related to paying wages and health benefits to employees who are not working as a result of closures and reduced receipts associated with COVID-19; and

 

apply any tax loss incurred in 2020 to prior year income for a refund when our 2020 tax return is filed.

 

The Company continues to review, and intends to seek, any other available potential benefits under the Cares Act as well as any future legislation signed into law during 2020.

3.

New Accounting Pronouncements

ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, (“ASU 2019-12”).  The purpose of ASU 2019-12 is to simplify the accounting for income taxes.  The improvements in ASU 2019-12 include removing certain exceptions for recognizing deferred taxes for investments, performing intraperiod allocation and calculating income taxes in interim periods. ASU 2019-12 also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill and allocating taxes to members of a consolidated group.  ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, including interim periods within that year.  The amendments in ASU 2019-12 should be applied prospectively.  The Company is evaluating the impact of ASU 2019-12 and does not expect ASU-2019-12 to have a significant impact on the condensed consolidated financial statements.

ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, (“ASU 2020-04”). The purpose of ASU 2020-04 is to provide optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. More specifically, the amendments in ASU 2020-04 provide optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met.  The amendments in ASU 2020-04 are effective as of March 12, 2020 through December 31, 2022. The Company is evaluating the impact of ASU 2020-04 and its impact on the condensed consolidated financial statements.


9


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

4.

Lease Accounting

The following table represents the Company’s aggregate lease costs, by lease classification, for the periods presented.

 

 

 

Three Months Ended

 

 

 

March 31,

 

Lease Cost

Classification

2020

 

 

2019

 

Operating lease costs

 

 

 

 

 

 

 

 

Equipment (1)

Utilities and other

$

1,541

 

 

$

1,743

 

Real Estate (2)(3)

Facility lease expense

 

81,658

 

 

 

84,785

 

Total operating lease costs

 

$

83,199

 

 

$

86,528

 

 

 

 

 

 

 

 

 

 

Finance lease costs

 

 

 

 

 

 

 

 

Amortization of leased assets

Depreciation and amortization

$

3,707

 

 

$

3,740

 

Interest on lease liabilities

Interest expense

 

1,851

 

 

 

2,021

 

Total finance lease costs

 

$

5,558

 

 

$

5,761

 

(1)

Includes approximately $413 and $620 of short-term lease payments for the three months ended March 31, 2020 and 2019, respectively.  

(2)

Includes approximately $12,247 and $15,934 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the three months ended March 31, 2020 and 2019, respectively.

(3)

Approximately $460 and $402 of lease payments are included in general and administrative expenses primarily related to office leases for the three months ended March 31, 2020 and 2019, respectively.  

 

The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of assets for the periods indicated.

 

 

 

Three Months Ended

 

 

 

March 31,

 

Other Information

 

2020

 

 

2019

 

Cash paid for amounts included in the measurement of lease liabilities

 

 

 

 

 

 

 

 

Cash outflows for operating leases

 

$

70,539

 

 

$

69,974

 

Cash outflows for finance leases - operating activities

 

$

1,811

 

 

$

1,974

 

Cash outflows for finance leases - financing activities

 

$

3,789

 

 

$

3,517

 

Non-cash amount of leased assets obtained in exchange for:

 

 

 

 

 

 

 

 

Operating lease liabilities - real estate

 

$

37,615

 

 

$

 

Operating lease liabilities - equipment

 

$

188

 

 

$

101

 

Finance lease liabilities

 

$

 

 

$

 

As of March 31, 2020, the Company had signed lease agreements with total noncancelable lease payments of approximately $220,403 related to theatre leases that had not yet commenced.  The timing of lease commencement is dependent on the completion of construction of the related theatre facility.  Additionally, these amounts are based on estimated square footage and costs to construct each facility and may be subject to adjustment upon final completion of each construction project.  In accordance with ASC Topic 842, fixed minimum lease payments related to these theatres are not included in the right-of-use assets and lease liabilities as of March 31, 2020.  There were no noncancelable lease agreements signed, but not yet commenced, related to equipment leases as of March 31, 2020.  


10


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

 

5.

Revenue Recognition

 

The Company’s patrons have the option to purchase movie tickets well in advance of a movie showtime or right before the movie showtime, or at any point in between those two timeframes depending on seat availability. The Company recognizes such admissions revenues when the showtime for a purchased movie ticket has passed. Concession revenues are recognized when products are sold to the consumer. Other revenues primarily consist of screen advertising and screen rental revenues, promotional income, studio trailer placements and transactional fees. The Company sells gift cards and discount ticket vouchers, the proceeds from which are recorded as deferred revenues. Deferred revenues for gift cards and discount ticket vouchers are recognized when they are redeemed for concession items or, if redeemed for movie tickets, when the showtime has passed. The Company offers a subscription program in the U.S. whereby patrons can pay a monthly fee to receive a monthly credit for use towards a future movie ticket purchase. The Company records the monthly subscription program fees as deferred revenues and records admissions revenues when the showtime for a movie ticket purchased with a credit has passed.  The Company has loyalty programs in the U.S. and many of its international locations that either have a prepaid annual membership fee or award points to customers as purchases are made. For those loyalty programs that have an annual membership fee, the Company recognizes the fee collected as other revenues on a straight-line basis over the term of the membership.  For those loyalty programs that award points to customers based on their purchases, the Company records a portion of the original transaction proceeds as deferred revenues based on the number of reward points issued to customers and recognizes the deferred revenues when the customer redeems such points. The value of loyalty points issued is based on the estimated fair value of the rewards offered. The Company records breakage revenue on gift cards and discount ticket vouchers generally based on redemption activity and historical experience with unused balances. The Company records breakage revenue upon the expiration of loyalty points and subscription credits. Advances collected on concession and other contracts are deferred and recognized during the period in which the Company satisfies the related performance obligations, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as the Company meets its performance obligations in accordance with the terms of the contracts.

Accounts receivable as of March 31, 2020 and December 31, 2019 included approximately $19,016 and $31,620 of receivables, respectively, related to contracts with customers.  The Company did not record any assets related to the costs to obtain or fulfill a contract with customers during the three months ended March 31, 2020 or March 31, 2019.

 

Disaggregation of Revenue

The following table presents revenues for the three months ended March 31, 2020 and 2019, disaggregated based on major type of good or service and by reportable operating segment.

 

 

Three Months Ended

 

 

 

March 31, 2020

 

 

 

U.S.

 

 

International

 

 

 

 

 

 

 

Operating

 

 

Operating

 

 

 

 

 

Major Goods/Services

 

Segment (1)

 

 

Segment

 

 

Consolidated

 

Admissions revenues

 

$

232,326

 

 

$

60,136

 

 

$

292,462

 

Concession revenues

 

 

152,758

 

 

 

37,598

 

 

 

190,356

 

Screen advertising, screen rental and promotional revenues

 

 

18,209

 

 

 

12,446

 

 

 

30,655

 

Other revenues

 

 

24,150

 

 

 

5,993

 

 

 

30,143

 

Total revenues

 

$

427,443

 

 

$

116,173

 

 

$

543,616

 

 


11


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

 

 

 

Three Months Ended

 

 

 

March 31, 2019

 

 

 

U.S.

 

 

International

 

 

 

 

 

 

 

Operating

 

 

Operating

 

 

 

 

 

Major Goods/Services

 

Segment (1)

 

 

Segment

 

 

Consolidated

 

Admissions revenues

 

$

308,839

 

 

$

86,701

 

 

$

395,540

 

Concession revenues

 

 

199,386

 

 

 

51,938

 

 

 

251,324

 

Screen advertising, screen rental and promotional revenues

 

 

20,580

 

 

 

14,038

 

 

 

34,618

 

Other revenues

 

 

26,011

 

 

 

7,230

 

 

 

33,241

 

Total revenues

 

$

554,816

 

 

$

159,907

 

 

$

714,723

 

 

(1)

U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 17 for additional information on intercompany eliminations.

The following table presents revenues for the three months ended March 31, 2020 and 2019, disaggregated based on timing of revenue recognition.

 

 

 

Three Months Ended

 

 

 

 

March 31, 2020

 

 

 

 

U.S.

 

 

International

 

 

 

 

 

 

 

 

Operating

 

 

Operating

 

 

 

 

 

 

 

 

Segment (1)

 

 

Segment

 

 

Consolidated

 

Goods and services transferred at a point in time

 

 

$

401,442

 

 

$

101,252

 

 

$

502,694

 

Goods and services transferred over time

 

 

 

26,001

 

 

 

14,921

 

 

 

40,922

 

Total

 

 

$

427,443

 

 

$

116,173

 

 

$

543,616

 

 

 

 

 

Three Months Ended

 

 

 

 

March 31, 2019

 

 

 

 

U.S.

 

 

International

 

 

 

 

 

 

 

 

Operating

 

 

Operating

 

 

 

 

 

 

 

 

Segment (1)

 

 

Segment

 

 

Consolidated

 

Goods and services transferred at a point in time

 

 

$

532,183

 

 

$

143,109

 

 

$

675,292

 

Goods and services transferred over time

 

 

 

22,633

 

 

 

16,798

 

 

 

39,431

 

Total

 

 

$

554,816

 

 

$

159,907

 

 

$

714,723

 

 

(1)

U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 17 for additional information on intercompany eliminations.


12


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

Deferred Revenues

The following table presents changes in the Company’s advances and deferred revenues for the three months ended March 31, 2020.  

 

 

NCM screen advertising advances (1)

 

 

Other

Deferred

Revenues (2)

 

 

Total

 

Balance at January 1, 2020

 

$

348,354

 

 

$

138,426

 

 

$

486,780

 

Amounts recognized as accounts receivable

 

 

 

 

 

1,354

 

 

 

1,354

 

Cash received from customers in advance

 

 

 

 

 

44,870

 

 

 

44,870

 

Common units received from NCM (see Note 9)

 

 

3,620

 

 

 

 

 

 

3,620

 

Interest accrued related to significant financing component

 

 

5,891

 

 

 

 

 

 

5,891

 

Revenue recognized during period

 

 

(7,761

)

 

 

(43,943

)

 

 

(51,704

)

Foreign currency translation adjustments

 

 

 

 

 

(1,595

)

 

 

(1,595

)

Balance at March 31, 2020

 

$

350,104

 

 

$

139,112

 

 

$

489,216

 

 

(1)

See Note 9 for the maturity of balance as of March 31, 2020.

 

(2)

Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising, screen rental and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet.

The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of March 31, 2020 and when the Company expects to recognize this revenue.

 

 

Twelve Months Ended March 31,

 

 

 

 

 

 

 

 

 

Remaining Performance Obligations

 

2021

 

 

2022

 

 

2023

 

 

2024

 

 

2025

 

 

Thereafter

 

 

Total

 

Other Deferred revenue

 

 

124,099

 

 

 

14,868

 

 

 

145

 

 

 

 

 

 

 

 

 

 

$

 

139,112

 

 

 

6.

Earnings Per Share

The Company considers its unvested share based payment awards, which contain non-forfeitable rights to dividends, participating securities, and includes such participating securities in its computation of earnings per share pursuant to the two-class method. Basic earnings per share for the two classes of stock (common stock and unvested restricted stock) is calculated by dividing net income by the weighted average number of shares of common stock and unvested restricted stock outstanding during the reporting period. Diluted earnings per share is calculated using the weighted average number of shares of common stock plus the potentially dilutive effect of common equivalent shares outstanding determined under both the two class method and the treasury stock method.

The following table presents computations of basic and diluted earnings per share under the two-class method:

 

 

 

Three Months Ended

 

 

 

 

March 31,

 

 

 

 

2020

 

 

2019

 

Numerator:

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to Cinemark Holdings, Inc.

 

 

$

(59,591

)

 

$

32,728

 

Loss (earnings) allocated to participating share-based awards (1)

 

 

 

350

 

 

 

(183

)

Net income (loss) attributable to common stockholders

 

 

$

(59,241

)

 

$

32,545

 

 

 

 

 

 

 

 

 

 

 

Denominator (shares in thousands):

 

 

 

 

 

 

 

 

 

Basic weighted average common stock outstanding

 

 

 

116,496

 

 

 

116,179

 

Common equivalent shares for restricted stock units (2)

 

 

$

 

 

 

239

 

Diluted common equivalent shares

 

 

 

116,496

 

 

 

116,418

 

 

 

 

 

 

 

 

 

 

 

Basic earnings (loss) per share attributable to common stockholders

 

 

$

(0.51

)

 

$

0.28

 

Diluted earnings (loss) per share attributable to common stockholders

 

 

$

(0.51

)

 

$

0.28

 

 

 

(1)

For the three months ended March 31, 2020 and 2019, a weighted average of approximately 683 and 659 shares of restricted stock, respectively, were considered participating securities.  

 

(2)

For the three months ended March 31, 2020, approximately 92 common equivalent shares for restricted stock units were excluded because they were anti-dilutive.

13


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

 

7.

Long Term Debt Activity

Senior Secured Credit Facility

Cinemark USA, Inc. has a senior secured credit facility that includes a $700,000 term loan and a $100,000 revolving credit line (the “Credit Agreement”).  On March 25, 2020, the Company borrowed $98,800 under the revolving credit line of the Credit Agreement.  

As of March 31, 2020, there was $644,678 outstanding under the term loan and $98,800 outstanding under the revolving credit line.   As of March 31, 2020, approximately $71 was available for borrowing after giving effect to a letter of credit outstanding.  On April 3, 2020, the letter of credit was cancelled and was no longer outstanding.   Quarterly principal payments of $1,649 are due on the term loan through December 31, 2024, with a final principal payment of $613,351 due on March 29, 2025.  The revolving credit line matures November 28, 2022.

The average interest rate on outstanding term loan borrowings under the Credit Agreement at March 31, 2020 was approximately 3.5% per annum, after giving effect to the interest rate swap agreements discussed below.  The average interest rate on the outstanding revolver borrowings was 2.9% at March 31, 2020.

Interest Rate Swap Agreements

During the three months ended March 31, 2020, the Company amended and extended its three existing interest rate swap agreements and entered into a new interest rate swap agreement, all of which are used to hedge a portion of the interest rate risk associated with the variable interest rates on the Company’s term loan debt and qualify for cash flow hedge accounting. Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of March 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Estimated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value at

 

Notional

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

 

Amount

 

 

Effective Date

 

Pay Rate

 

 

Receive Rate

 

Expiration Date

 

2020 (1)

 

$

137,500

 

 

December 31, 2018

 

2.12%

 

 

1-Month LIBOR

 

December 31, 2024

 

$

11,332

 

$

175,000

 

 

December 31, 2018

 

2.12%

 

 

1-Month LIBOR

 

December 31, 2024

 

 

14,447

 

$

137,500

 

 

December 31, 2018

 

2.19%

 

 

1-Month LIBOR

 

December 31, 2024

 

 

11,800

 

$

150,000

 

 

March 31, 2020

 

0.57%

 

 

1-Month LIBOR

 

March 31, 2022

 

 

881

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

38,460

 

 

(1)

Approximately $8,949 of the total is included in accounts payable and accrued expenses and $29,511 is included in other long-term liabilities on the condensed consolidated balance sheet as of March 31, 2020.

  Upon amending the interest rate swap agreements, the Company determined that the interest payments hedged with the agreements are still probable to occur, therefore the loss that accumulated on the swaps prior to the amendments of $29,359 will be amortized on a straight-line basis to interest expense through December 31, 2022, the original maturity dates of the swaps.   The fair values of the amended interest rate swaps and the new interest rate swap are recorded on the Company’s condensed consolidated balance sheet as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss.  The changes in fair value are reclassified from accumulated other comprehensive loss into earnings in the same period that the hedged items affect earnings. The valuation technique used to determine fair value is the income approach.  Under this approach, the Company uses projected future interest rates, which fall in Level 2 of the U.S. GAAP hierarchy as defined by FASB ASC Topic 820-10-35, as provided by counterparties to the interest rate swap agreements and the fixed rates that the Company is obligated to pay under the agreements.

Fair Value of Long-Term Debt

The Company estimates the fair value of its long-term debt using the market approach, which utilizes quoted market prices that fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by ASC 820, Fair Value Measurement (“ASC Topic 820”). The carrying value of the Company’s long-term debt was $1,898,478 and $1,801,327 as of March 31, 2020 and December 31, 2019, respectively, excluding unamortized debt discounts and debt issue costs. The fair value of the Company’s long-term debt was $1,490,842 and $1,826,503 as of March 31, 2020 and December 31, 2019, respectively.

 

14


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

8.

Equity

Below is a summary of changes in stockholders’ equity attributable to Cinemark Holdings, Inc., noncontrolling interests and total equity for the three months ended March 31, 2020 and 2019:

 

 

Common  Stock

 

Treasury Stock

 

Additional Paid-In-Capital

 

Retained Earnings

 

Accumulated Other Comprehensive Loss

 

Total Cinemark Holdings, Inc. Stockholders’ Equity

 

Noncontrolling Interests

 

Total Equity

 

Balance at January 1, 2020

 

$

122

 

$

(81,567

)

$

1,170,039

 

$

687,332

 

$

(340,112

)

$

1,435,814

 

$

12,508

 

$

1,448,322

 

Issuance of share based awards and share based awards compensation expense

 

 

 

 

 

 

4,111

 

 

 

 

 

 

4,111

 

 

 

 

4,111

 

Stock withholdings related to share based awards that vested during the three months ended March 31, 2020

 

 

 

 

(2,691

)

 

 

 

 

 

 

 

(2,691

)

 

 

 

(2,691

)

Dividends paid to stockholders, $0.36 per common share (1)

 

 

 

 

 

 

 

 

(42,311

)

 

 

 

(42,311

)

 

 

 

(42,311

)

Dividends paid to noncontrolling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(392

)

 

(392

)

Dividends accrued on unvested restricted stock unit awards (1)

 

 

 

 

 

 

 

 

(256

)

 

 

 

(256

)

 

 

 

(256

)

Net income (loss)

 

 

 

 

 

 

 

 

(59,591

)

 

 

 

(59,591

)

 

169

 

 

(59,422

)

Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements

 

 

 

 

 

 

 

 

 

 

(24,171

)

 

(24,171

)

 

 

 

(24,171

)

Foreign currency translation adjustments

 

 

 

 

 

 

 

 

 

 

(57,625

)

 

(57,625

)

 

 

 

(57,625

)

Balance at March 31, 2020

 

$

122

 

$

(84,258

)

$

1,174,150

 

$

585,174

 

$

(421,908

)

$

1,253,280

 

$

12,285

 

$

1,265,565

 

 

 

 

Common  Stock

 

Treasury Stock

 

Additional Paid-In-Capital

 

Retained Earnings

 

Accumulated Other Comprehensive Loss

 

Total Cinemark Holdings, Inc. Stockholders’ Equity

 

Noncontrolling Interests

 

Total Equity

 

Balance at January 1, 2019

 

$

121

 

$

(79,259

)

$

1,155,424

 

$

638,912

 

$

(319,007

)

$

1,396,191

 

$

12,379

 

$

1,408,570

 

Cumulative effect of change in accounting principle, net of taxes of $6,054

 

 

 

 

 

 

 

 

16,985

 

 

 

 

16,985

 

 

 

 

16,985

 

Issuance of share based awards and share based awards compensation expense

 

 

 

 

 

 

2,970

 

 

 

 

 

 

 

2,970

 

 

 

 

2,970

 

Stock withholdings related to share based awards that vested during the three months ended March 31, 2019

 

 

 

 

(1,947

)

 

 

 

 

 

 

 

(1,947

)

 

 

 

(1,947

)

Dividends paid to stockholders, $0.34 per common share (1)

 

 

 

 

 

 

 

 

(39,797

)

 

 

 

(39,797

)

 

 

 

(39,797

)

Dividends paid to noncontrolling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,000

)

 

(1,000

)

Dividends accrued on unvested restricted stock unit awards (1)

 

 

 

 

 

 

 

 

(108

)

 

 

 

(108

)

 

 

 

(108

)

Net income

 

 

 

 

 

 

 

 

32,728

 

 

 

 

32,728

 

 

465

 

 

33,193

 

Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements

 

 

 

 

 

 

 

 

 

 

(3,311

)

 

(3,311

)

 

 

 

(3,311

)

Other comprehensive loss in equity method investees

 

 

 

 

 

 

 

 

 

 

(71

)

 

(71

)

 

 

 

(71

)

Foreign currency translation adjustments

 

 

 

 

 

 

 

 

 

 

755

 

 

755

 

 

 

 

755

 

Balance at March 31, 2019

 

$

121

 

$

(81,206

)

$

1,158,394

 

$

648,720

 

$

(321,634

)

$

1,404,395

 

$

11,844

 

$

1,416,239

 

 

 

(1)

Below is a summary of dividends paid to stockholders and accrued on unvested restricted stock unit awards during the three months ended March 31, 2020 and 2019:  

 

 

 

 

Amount per Share

 

 

 

 

 

Declaration Date

Record Date

Payable Date

 

of Common Stock

 

 

Total

 

2/21/2020

3/6/2020

3/20/2020

 

$

0.36

 

 

$

42,567

 

 

 

 

 

 

 

 

 

 

 

 

2/22/2019

3/8/2019

3/22/2019

 

$

0.34

 

 

$

39,905

 

 

15


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

9.

National CineMedia

Below is a summary of activity with NCM included in the Company’s condensed consolidated financial statements:

 

 

 

Investment

in NCM

 

NCM Screen Advertising Advances

 

Distributions

from NCM

 

Equity in

Earnings

 

Other

Revenue

 

Interest Expense - NCM

 

Cash Received

 

Balance as of January 1, 2020

 

$

265,792

 

$

(348,354

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Receipt of common units due to annual common unit adjustment ("CUA")

 

 

3,620

 

 

(3,620

)

$

 

$

 

$

 

$

 

$

 

Screen rental revenues earned under ESA (1)

 

 

 

 

 

 

 

 

 

 

(3,461

)

 

 

 

3,461

 

Interest accrued related to significant financing component

 

 

 

 

(5,891

)

 

 

 

 

 

 

 

5,891

 

 

 

Receipt of excess cash distributions

 

 

(10,567

)

 

 

 

(5,224

)

 

 

 

 

 

 

 

15,791

 

Equity in earnings

 

 

6,526

 

 

 

 

 

 

(6,526

)

 

 

 

 

 

 

Amortization of screen advertising advances

 

 

 

 

7,761

 

 

 

 

 

 

(7,761

)

 

 

 

 

Balance as of and for the three months ended March 31, 2020

 

$

265,371

 

$

(350,104

)

$

(5,224

)

$

(6,526

)

$

(11,222

)

$

5,891

 

$

19,252

 

 

(1)

Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $2,134.

 

Investment in National CineMedia

 

NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. The Company entered into an Exhibitor Services Agreement with NCM (“ESA”), pursuant to which NCM primarily provides advertising to our theatres. As described in Note 7 to the Company’s financial statements as included in its 2019 Annual Report on Form 10-K, on February 13, 2007, National Cinemedia, Inc. (“NCMI”), an entity that serves as the sole manager of NCM, completed an initial public offering (“IPO”) of its common stock.  In connection with the NCMI initial public offering, the Company amended its operating agreement and the ESA. At the time of the NCMI IPO and as a result of amending the ESA, the Company received approximately $174,000 in cash consideration from NCM.  The proceeds were recorded as deferred revenue or NCM screen advertising advances and was being amortized over the term of the Amended and Restated ESA, or through February 2041. Following the NCMI IPO, the Company does not recognize undistributed equity in the earnings on its original NCM membership units (referred to herein as the Company’s Tranche 1 Investment) until NCM’s future net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company recognizes cash distributions it receives from NCM on its Tranche 1 Investment as a component of earnings as Distributions from NCM.  The Company believes that the accounting model provided by ASC Topic 323-10-35-22 for recognition of equity investee losses in excess of an investor’s basis is analogous to the accounting for equity income subsequent to recognizing an excess distribution.

Common Unit Adjustments

In addition to the consideration received upon the NCMI IPO and ESA modification in 2007, the Company also periodically receives consideration in the form of common units from NCM.  Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated. As discussed in Note 7 to the Company’s financial statements as included in its 2019 Annual Report on Form 10-K, the common units received (collectively referred to as the Company’s “Tranche 2 Investment”) are recorded at estimated fair value as an increase in the Company’s investment in NCM with an offset to NCM screen advertising advances. The Company’s Tranche 2 Investment is accounted for following the equity method, with undistributed equity earnings related to its Tranche 2 Investment included as a component of earnings in equity in income of affiliates and distributions received related to its Tranche 2 Investment are recorded as a reduction of investment basis.

 

16


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

During March 2020, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, on March 31, 2020, the Company received an additional 1,112,368 common units of NCM, each of which is convertible into one share of NCMI common stock. The Company recorded the additional common units received at estimated fair value with a corresponding adjustment to NCM screen advertising advances of approximately $3,620. The fair value of the common units received was estimated based on the market price of NCMI common stock at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares.

As of March 31, 2020, the Company owned a total of 40,850,068 common units of NCM, representing an ownership interest of approximately 25%. Each of the Company’s common units in NCM is convertible into one share of NCM, Inc. common stock.  As of March 31, 2020, the estimated fair value of the Company’s investment in NCM was approximately $133,171 based on NCM, Inc.’s stock price as of March 31, 2020 of $3.26 per share (Level 1 input as defined in FASB ASC Topic 820), which was below the Company’s carrying value of $265,371.  The market value of NCM, Inc.’s stock price may vary due to the performance of the business, industry trends, general and economic conditions and other factors, including those resulting from the impact of COVID-19 (see Note 2).  The Company does not believe that the decline in NCM, Inc.’s stock price is other than temporary as the Company and other industry participants, who are also members of the NCM network, are planning to reopen theatres in the next few months, and the Company expects industry attendance to recover gradually over time.  Therefore, no impairment of the Company’s investment in NCM was recorded during the three months ended March 31, 2020.  

Exhibitor Services Agreement

As discussed above, the Company’s domestic theatres are part of the in-theatre digital network operated by NCM under the ESA. NCM provides advertising to the Company’s theatres through its branded “Noovie” pre-show entertainment program and also handles lobby promotions and displays for our theatres.  The Company receives a monthly theatre access fee for participation in the NCM network and also earns screen advertising revenue on a per patron basis.   Prior to September 17, 2019, the ESA was accounted for under ASC Topic 606, Revenue from Contracts with Customers.  Effective September 17, 2019, the Company signed an amendment to the ESA, under which the Company will provide incremental advertising time to NCM and has extended the term through February 2041.  Subsequent to the amendment, the ESA is accounted for as a lease under ASC Topic 842.  The Company leases nonconsecutive periods of use of its domestic theatre screens to NCM for purposes of showing third party advertising content.  The lease requires variable lease payments based on the number of patrons attending the showtimes during which such advertising is shown.  The screen advertising revenues earned under the ESA, both before and after the amendment, are reflected in other revenue on the condensed consolidated income statement.  

The recognition of revenue related to the NCM screen advertising advances will be recorded on a straight-line basis through February 2041.

 

 

 

Twelve Months Ended March 31,

 

 

 

 

 

 

 

 

 

Remaining Maturity

 

2021

 

 

2022

 

 

2023

 

 

2024

 

 

2025

 

 

Thereafter

 

 

Total

 

NCM screen advertising advances

 

$

7,865

 

 

$

8,407

 

 

$

8,989

 

 

$

9,612

 

 

$

10,279

 

 

$

304,952

 

 

$

350,104

 

 

Significant Financing Component

Prior to the September 17, 2019 amendment of the ESA, the Company applied a significant financing component, as required by ASC Topic 606, due to the significant length of time between receiving the NCM screen advertising advances (the $174,000 received at the NCMI IPO and the periodic common unit adjustments) and completion of the performance obligation. Effective September 17, 2019, upon the Company’s evaluation and determination that ASC Topic 842 applies to the amended ESA, the Company determined it acceptable to apply the significant financing component guidance from ASC Topic 606 by analogy as the economic substance of the agreement represents a financing arrangement. As a result of the significant financing component, the Company recognized incremental screen rental revenue and an offsetting interest expense of $5,891 and $4,782 during the three months ended March 31, 2020 and 2019, respectively. The interest expense was calculated using the Company’s incremental borrowing rates at the time when the cash and each tranche of common units were received from NCM, which ranged from 4.3% to 8.3%.

 


17


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

NCM Financial Information

Below is summary financial information for NCM for the periods indicated:

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

March 26, 2020

 

 

March 28, 2019

 

Gross revenues

 

$

64,700

 

 

$

76,900

 

Operating income

 

$

4,900

 

 

$

10,900

 

Net loss

 

$

(8,600

)

 

$

(2,900

)

 

 

 

As of

 

 

As of

 

 

 

March 26, 2020

 

 

December 26, 2019

 

Current assets

 

$

248,900

 

 

$

185,400

 

Noncurrent assets

 

$

710,100

 

 

$

706,600

 

Current liabilities

 

$

68,600

 

 

$

125,500

 

Noncurrent liabilities

 

$

1,075,600

 

 

$

947,800

 

Members deficit

 

$

(185,200

)

 

$

(181,300

)

 

 

10.

Other Investments

Below is a summary of activity for each of the Company’s other investments for the three months ended March 31, 2020:

 

 

 

DCIP

 

AC JV,

LLC

 

DCDC

 

FE Concepts

 

Other

 

Total

 

Balance at January 1, 2020

 

$

124,696

 

$

5,022

 

$

3,169

 

$

19,519

 

$

2,879

 

$

155,285

 

Cash distributions received

 

 

(5,161

)

 

 

 

(878

)

 

 

 

 

 

(6,039

)

Equity in income (loss)

 

 

1,249

 

 

740

 

 

194

 

 

(223

)

 

 

 

1,960

 

Other

 

 

50

 

 

 

 

 

 

 

 

(24

)

 

26

 

Balance at March 31, 2020

 

$

120,834

 

$

5,762

 

$

2,485

 

$

19,296

 

$

2,855

 

$

151,232

 

 

Digital Cinema Implementation Partners LLC (“DCIP”)

On February 12, 2007, the Company, AMC and Regal (the “Exhibitors”) entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. On March 10, 2010, DCIP and its subsidiaries completed an initial financing transaction to enable the purchase, deployment and leasing of digital projection systems to the Exhibitors under equipment lease and installation agreements.  On March 31, 2011, DCIP obtained incremental financing necessary to complete the deployment of digital projection systems.  DCIP also entered into long-term Digital Cinema Deployment Agreements (“DCDAs”) with six major motion picture studios pursuant to which Kasima LLC, one of DCIP’s subsidiaries, receives a virtual print fee ("VPF") each time the studio books a film or certain other content on the leased digital projection systems. Other content distributors entered into similar DCDAs that provide for the payment of VPFs for bookings of the distributor's content on a leased digital projection system.  The DCDAs end on the earlier to occur of (i) the tenth anniversary of the "mean deployment date" for all digital projection systems scheduled to be deployed over a period of up to five years, or (ii) the date DCIP achieves "cost recoupment", each as defined in the DCDAs.  Cost recoupment occurs when revenues attributable to the digital projection systems exceed the financing, deployment, administration and other costs associated with the purchase of the digital projection systems.  DCIP expects cost recoupment to occur during 2021. The timing of cost recoupment is dependent on VPF payments from studios. Pursuant to the operating agreement between the Exhibitors and DCIP, DCIP began to distribute excess cash to the Exhibitors upon the payoff of its outstanding debt, which occurred during the year ended December 31, 2019.  

As of March 31, 2020, the Company had a 33% voting interest in DCIP and a 24.3% economic interest in DCIP. The Company accounts for its investment in DCIP and its subsidiaries under the equity method of accounting.

18


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

Below is summary financial information for DCIP for the periods indicated:

 

 

 

Three Months Ended

 

 

 

 

March 31, 2020

 

 

March 31, 2019

 

 

Gross revenues

 

$

32,510

 

 

$

44,774

 

 

Operating income (loss)

 

$

(5,239

)

 

$

20,208

 

 

Net income (loss)

 

$

(11,140

)

 

$

18,485

 

 

 

 

 

As of

 

 

 

March 31, 2020

 

 

December 31, 2019

 

Current assets

 

$

40,241

 

 

$

51,382

 

Noncurrent assets

 

$

531,867

 

 

$

581,547

 

Current liabilities

 

$

55,737

 

 

$

70,515

 

Noncurrent liabilities

 

$

159

 

 

$

190

 

Members' equity

 

$

516,212

 

 

$

562,224

 

 

As of March 31, 2020, the Company had 3,866 digital projection systems being leased under the master equipment lease agreement with Kasima LLC, which is an indirect subsidiary of DCIP and a related party to the Company. The Company had the following transactions with DCIP, reflected in utilities and other costs on the condensed consolidated statements of income, during the three months ended March 31, 2020 and 2019:

 

 

 

 

Three Months Ended

 

 

 

 

March 31, 2020

 

 

March 31, 2019

 

Equipment lease payments

 

 

$

1,038

 

 

$

1,121

 

Warranty reimbursements from DCIP

 

 

$

(3,123

)

 

$

(2,938

)

Management service fees

 

 

$

84

 

 

$

158

 

AC JV, LLC

During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a joint venture that owns “Fathom Events” formerly operated by NCM.  The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators, including concerts, opera and symphony, DVD product releases and marketing events, theatrical premieres, Broadway plays, live sporting events and other special events. The Company paid event fees to AC of $1,673 and $5,317 for the three months ended March 31, 2020 and 2019, respectively, which are included in film rentals and advertising costs on the condensed consolidated statements of income. The Company accounts for its investment in AC under the equity method of accounting.

Digital Cinema Distribution Coalition

Digital Cinema Distribution Coalition (“DCDC”) is a joint venture among the Company, Universal, Warner Bros., AMC and Regal.  DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $105 and $263 to DCDC during the three months ended March 31, 2020 and 2019, respectively, related to content delivery services provided by DCDC.  These fees are included in film rentals and advertising costs on the condensed consolidated statements of income. The Company accounts for its investment in DCDC under the equity method of accounting.

FE Concepts, LLC

During April 2018, the Company, through its wholly-owned indirect subsidiary CNMK Texas Properties, LLC (“CNMK”), formed a joint venture, FE Concepts, LLC (“FE Concepts”) with AWSR Investments, LLC (“AWSR”), an entity owned by Lee Roy Mitchell and Tandy Mitchell.  FE Concepts operates a family entertainment center that offers bowling, gaming, movies and other amenities that opened during December 2019.  The Company and AWSR each invested approximately $20,000 and each have a 50% voting interest in FE Concepts.  The Company accounts for its investment in FE Concepts under the equity method of accounting.  The Company has a theatre services agreement with FE Concepts under which it provides film booking and equipment monitoring services.  The Company recorded $10 of theatre services revenue under the agreement during the three months ended March 31, 2020.

 

19


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

Additional Considerations

 

Each of the investments above have been temporarily impacted by the COVID-19 pandemic (see Note 2) due to the temporary closure of theatres across the U.S.  The Company does not believe that any resulting decline in value of the underlying investments is other than temporary as the Company and other industry participants, who also have equity ownership interests in certain of the above investments, are planning to reopen theatres during the next few months, and the Company expects industry attendance to recover gradually over time.

11.

Treasury Stock and Share Based Awards

Treasury Stock — Treasury stock represents shares of common stock repurchased or withheld by the Company and not yet retired. The Company has applied the cost method in recording its treasury shares.  Below is a summary of the Company’s treasury stock activity for the three months ended March 31, 2020:

 

 

 

Number of

 

 

 

 

 

 

 

Treasury

 

 

 

 

 

 

 

Shares

 

 

Cost

 

Balance at January 1, 2020

 

 

4,711,859

 

 

$

81,567

 

Restricted stock withholdings (1)

 

 

86,957

 

 

 

2,691

 

Restricted stock forfeitures

 

 

11,244

 

 

 

 

Balance at March 31, 2020

 

 

4,810,060

 

 

$

84,258

 

 

(1)

The Company withheld restricted shares as a result of the election by certain employees to satisfy their tax liabilities upon vesting in restricted stock and restricted stock units.  The Company determined the number of shares to be withheld based upon market values ranging from $12.30 to $32.12 per share.

As of March 31, 2020, the Company had no plans to retire any shares of treasury stock.

Restricted Stock – During the three months ended March 31, 2020, the Company granted 353,196 shares of restricted stock to employees. The fair value of the restricted stock granted was determined based on the market value of the Company’s common stock on the date of grant, which was $32.12 per share. The Company assumed forfeiture rates for the restricted stock awards that ranged from 0% to 10%.  The restricted stock awards vest over periods ranging from one to four years. The recipients of restricted stock are entitled to receive non-forfeitable dividends and to vote their respective shares, however, the sale and transfer of the restricted shares is prohibited during the restriction period.

Below is a summary of restricted stock activity for the three months ended March 31, 2020:

 

 

 

Shares of

 

 

Weighted

Average

 

 

 

Restricted

 

 

Grant Date

 

 

 

Stock

 

 

Fair Value

 

Outstanding at January 1, 2020

 

 

783,823

 

 

$

37.53

 

Granted

 

 

353,196

 

 

$

32.12

 

Vested

 

 

(260,278

)

 

$

35.05

 

Forfeited

 

 

(11,244

)

 

$

37.52

 

Outstanding at March 31, 2020

 

 

865,497

 

 

$

36.07

 

Unvested restricted stock at March 31, 2020

 

 

865,497

 

 

$

36.07

 

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Compensation expense recognized during the period

 

$

2,691

 

 

$

2,433

 

Fair value of restricted shares that vested during the period

 

$

8,029

 

 

$

5,745

 

Income tax benefit recognized upon vesting of restricted stock awards

 

$

2,418

 

 

$

1,002

 

 

As of March 31, 2020, the estimated remaining unrecognized compensation expense related to unvested restricted stock awards was $22,864 and the weighted average period over which this remaining compensation expense will be recognized is approximately three years.

20


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

Restricted Stock Units – During the three months ended March 31, 2020, the Company granted restricted stock units representing 436,681 hypothetical shares of common stock to employees. The restricted stock units vest based on a combination of financial performance factors and continued service. The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) during the two fiscal year periods ending December 31, 2021 based on a formula utilizing a multiple of Adjusted EBITDA subject to certain adjustments as specified by the Compensation Committee prior to the grant date. The financial performance factors for the restricted stock units have a threshold, target and maximum level of payment opportunity and vest on a prorata basis according to the IRR achieved by the Company during the performance period. If the IRR for the two-year period is at least 6%, which is the threshold, one-third of the maximum restricted stock units vest. If the IRR for the two-year period is at least 8%, which is the target, two-thirds of the maximum restricted stock units vest. If the IRR for the two-year period is at least 14%, which is the maximum, 100% of the maximum restricted stock units vest. Grantees are eligible to receive a ratable portion of the common stock issuable if the IRR is within the targets previously noted. Further, as an example, if the Company achieves an IRR equal to 11%, the number of restricted stock units that shall vest will be greater than the target but less than the maximum number that would have vested had the Company achieved the highest IRR.  All restricted stock units granted during 2020 will vest subject to an additional two-year service requirement and will be paid in the form of common stock if the participant continues to provide services through the fourth anniversary of the grant date. Restricted stock unit award participants are eligible to receive dividend equivalent payments from the grant date if, and at the time that, the restricted stock unit awards vest.  

Below is a table summarizing the potential number of shares that could vest under restricted stock unit awards granted during the three months ended March 31, 2020 at each of the three target levels of financial performance (excluding forfeiture assumptions):

 

 

 

Number of

 

 

 

 

 

 

 

Shares

 

 

Value at

 

 

 

Vesting

 

 

Grant

 

at IRR of at least 6%

 

 

190,707

 

 

$

6,125

 

at IRR of at least 8%

 

 

286,060

 

 

$

9,188

 

at IRR of at least 14%

 

 

436,681

 

 

$

14,026

 

 

Due to the fact that the IRR for the two-year performance period could not be determined at the time of the 2020 grant, the Company estimated that the most likely outcome is the achievement of the target IRR level. The fair value of the restricted stock unit awards was determined based on the closing price of the Company’s common stock on the date of grant, which was $32.12 per share. The Company assumed a forfeiture rate of 5% for the restricted stock unit awards. If during the service period, additional information becomes available to lead the Company to believe a different IRR level will be achieved for the two-year performance period, the Company will reassess the number of units that are expected to vest for the grant and adjust its compensation expense accordingly on a prospective basis over the remaining service period.

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Number of restricted stock unit awards that vested during the period

 

 

112,070

 

 

 

88,074

 

Fair value of restricted stock unit awards that vested during the period

 

$

3,554

 

 

$

3,550

 

Accumulated dividends paid upon vesting of restricted stock unit awards

 

$

544

 

 

$

375

 

Compensation expense recognized during the period

 

$

1,420

 

 

$

537

 

Income tax benefit recognized upon vesting of restricted stock unit awards

 

$

821

 

 

$

170

 

 

 

21


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

As of March 31, 2020, the estimated remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $17,185. The weighted average period over which this remaining compensation expense will be recognized is approximately three years. As of March 31, 2020, the Company had restricted stock units outstanding that represented a total of 1,008,288 hypothetical shares of common stock, net of forfeitures, assuming an IRR of 9.3% was achieved for the 2017 grants, an IRR of 8.6% was achieved for the 2018 grants and the maximum IRR level is achieved for all other grants outstanding.

12.

Goodwill and Other Intangible Assets

The Company’s goodwill was as follows:

 

 

 

U.S.

Operating

Segment

 

 

International

Operating

Segment

 

 

Total

 

Balance at January 1, 2020 (1)

 

$

1,182,853

 

 

$

100,518

 

 

$

1,283,371

 

Foreign currency translation adjustments

 

 

 

 

 

(14,812

)

 

 

(14,812

)

Balance at March 31, 2020 (1)

 

$

1,182,853

 

 

$

85,706

 

 

$

1,268,559

 

 

 

(1)

Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable.  Due to the temporary closure of the Company’s domestic theatres effective March 17, 2020 and international theatres effective March 18, 2020 as a result of the COVID-19 pandemic (see Note 2), the Company performed a quantitative goodwill impairment evaluation for all reporting units during the three months ended March 31, 2020.  The Company evaluates goodwill for impairment at the reporting unit level and has allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its twenty regions in the U.S. and seven countries internationally with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations).  Under the quantitative analysis, the Company estimated the fair value of each reporting unit and compared it with its carrying value.   Fair value was determined using the market approach and based on a multiple of cash flows for each reporting unit, which was eight times for the evaluations performed during the three months ended March 31, 2020.   The market approach is the most common valuation approach for the Company’s industry.  The Company also performed its goodwill impairment analysis using the income approach to further validate the results of the assessment results under the market approach. Significant judgment, including management’s estimate of the impact of temporary theatre closures and other considerations as a result of COVID-19, was involved in estimating cash flows and fair value.  The Company’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on projected operating performance of each reporting unit, market transactions and industry trading multiples.   The carrying value of the Company’s reporting units did not exceed estimated fair values at March 31, 2020. The estimated fair value of one of the Company’s reporting units exceeded its carrying value by less than 10%.  

Intangible assets consisted of the following:

 

 

 

Balance at

January 1, 2020

 

Amortization

 

Other (1)

 

Balance at March 31, 2020

 

Intangible assets with finite lives:

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross carrying amount

 

$

85,007

 

$

 

$

(1,798

)

$

83,209

 

Accumulated amortization

 

 

(63,924

)

 

(1,241

)

 

 

 

(65,165

)

Total net intangible assets with finite lives

 

$

21,083

 

$

(1,241

)

$

(1,798

)

$

18,044

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Intangible assets with indefinite lives:

 

 

 

 

 

 

 

 

 

 

 

 

 

Tradename and other

 

 

300,686

 

 

 

 

(73

)

 

300,613

 

Total intangible assets — net

 

$

321,769

 

$

(1,241

)

$

(1,871

)

$

318,657

 

 

(1)

Amount primarily represents foreign currency translation adjustments.

22


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

Due to the temporary closure of the Company’s theatres effective March 18, 2020 as a result of the COVID-19 pandemic (see Note 2), the Company performed a quantitative impairment evaluation for all definite and indefinite-lived tradename assets during the three months ended March 31, 2020.  Under the quantitative analysis, the Company compared the carrying values of tradename assets to their estimated fair values.  Fair values were estimated by applying an estimated market royalty rate that could be charged for the use of the tradenames to forecasted future revenues, with an adjustment for the present value of such royalties.  Significant judgment, including management’s estimate of the impact of temporary theatre closures and other considerations as a result of COVID-19, was involved in estimating market royalty rates and long-term revenue forecasts.  Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, were based on projected revenue performance and expected industry trends. The carrying values of the Company’s tradename assets did not exceed estimated fair values at March 31, 2020.

Estimated aggregate future amortization expense for intangible assets is as follows:

 

For the nine months ended December 31, 2020

 

$

3,655

 

For the twelve months ended December 31, 2021

 

 

2,801

 

For the twelve months ended December 31, 2022

 

 

2,648

 

For the twelve months ended December 31, 2023

 

 

2,550

 

For the twelve months ended December 31, 2024

 

 

2,550

 

Thereafter

 

 

3,840

 

Total

 

$

18,044

 

 

 

13.

Impairment of Long-Lived Assets

Due to the temporary closure of the Company’s theatres effective March 18, 2020 as a result of the COVID-19 pandemic (see Note 2), the Company performed a long-lived asset impairment evaluation for all theatres during the three months ended March 31, 2020.  The impairment evaluation was based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life.  Significant judgment, including management’s estimate of the impact of temporary theatre closures and other considerations as a result of COVID-19, was involved in estimating cash flows and fair value.  Fair value is determined based on a multiple of cash flows, which was six times for the evaluations performed during the three months ended March 31, 2020.   Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy, as defined by FASB ASC Topic 820-10-35, are based on projected operating performance, market transactions and industry trading multiples.

Below is a summary of impairment charges for the periods presented:

 

 

 

 

Three Months Ended

 

 

 

 

March 31,

 

 

 

 

2020

 

 

2019

 

U.S. Segment

 

 

 

 

 

 

 

 

 

Theatre properties

 

 

$

3,643

 

 

$

1,208

 

Theatre operating lease right-of-use assets

 

 

 

5,952

 

 

 

 

U.S. total

 

 

 

9,595

 

 

 

1,208

 

 

 

 

 

 

 

 

 

 

 

International segment

 

 

 

 

 

 

 

 

 

Theatre properties

 

 

 

4,484

 

 

 

4,376

 

Theatre operating lease right-of-use assets

 

 

 

2,540

 

 

 

 

International total

 

 

 

7,024

 

 

 

4,376

 

 

 

 

 

 

 

 

 

 

 

Total Impairment

 

 

$

16,619

 

 

$

5,584

 

 

 

23


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

14.

Fair Value Measurements

The Company determines fair value measurements in accordance with ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by ASC Topic 820 are as follows:

Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date;

Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and

Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available.

Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of March 31, 2020:

 

 

Carrying

 

 

Fair Value

 

Description

 

Value

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Interest rate swap liabilities (1)

 

$

38,460

 

 

$

 

 

$

38,460

 

 

$

 

 

(1)

See further discussion of interest rate swaps at Note 7.

Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2019:

 

 

Carrying

 

 

Fair Value

 

Description

 

Value

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Interest rate swap liabilities (1)

 

$

15,995

 

 

$

 

 

$

15,995

 

 

$

 

 

(1)

See further discussion of interest rate swaps at Note 7.

The Company uses the market approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its goodwill, intangible assets and long-lived assets (see Note 12 and Note 13). See additional explanation of fair value measurement techniques used for long-lived assets, goodwill and intangible assets in “Critical Accounting Policies” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, filed February 21, 2020.  There were no changes in valuation techniques.  The Company elected to perform its goodwill impairment evaluation using both the market approach and the income approach for the three months ended March 31, 2020.  There were no transfers in to or out of Level 1, Level 2 or Level 3 during the three months ended March 31, 2020.

15.

Foreign Currency Translation

The accumulated other comprehensive loss account in stockholders’ equity of $421,908 and $340,112 as of March 31, 2020 and December 31, 2019, respectively, primarily includes cumulative foreign currency net losses of $385,678 and $328,053, respectively, from translating the financial statements of the Company’s international subsidiaries and the cumulative changes in fair value of the Company’s interest rate swap agreements that are designated as hedges.

As of March 31, 2020, all foreign countries where the Company has operations, other than Argentina, are non-highly inflationary, and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss.  The Company deemed Argentina to be highly inflationary beginning July 1, 2018.  A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity.  The financial information of the Company’s Argentina subsidiaries has been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective beginning July 1, 2018.  

24


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

Below is a summary of the impact of translating the March 31, 2020 and 2019 financial statements of the Company’s international subsidiaries:

 

 

 

 

 

 

 

 

 

 

Other Comprehensive Income (Loss) for

 

 

 

Exchange Rate as of

 

 

Three Months Ended

 

Country

 

March 31, 2020

 

 

December 31, 2019

 

 

March 31, 2020

 

March 31, 2019

 

Brazil

 

 

5.20

 

 

 

4.02

 

 

$

(42,873

)

$

(2,334

)

Chile

 

 

857.94

 

 

 

736.86

 

 

 

(11,126

)

 

1,473

 

Colombia

 

 

4,064.81

 

 

 

3,277.14

 

 

 

(3,274

)

 

982

 

Peru

 

 

3.47

 

 

 

3.37

 

 

 

(1,450

)

 

431

 

All other

 

 

 

 

 

 

 

 

 

 

1,098

 

 

203

 

 

 

 

 

 

 

 

 

 

 

$

(57,625

)

$

755

 

 

(1)  

Beginning July 1, 2018, Argentina was deemed highly inflationary.  A loss of $294 and $394 for the three months ended March 31, 2020 and 2019, respectively, is reflected as foreign currency exchange gain (loss) on the Company’s condensed consolidated statement of income as a result of translating Argentina financial results to U.S. dollars.  

 

16.

Supplemental Cash Flow Information

 

The following is provided as supplemental information to the condensed consolidated statements of cash flows:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2020

 

 

2019

 

Cash paid for interest

 

$

8,774

 

 

$

9,104

 

Cash paid for income taxes, net of refunds received

 

$

2,110

 

 

$

3,414

 

Noncash investing and financing activities:

 

 

 

 

 

 

 

 

Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1)

 

$

2,269

 

 

$

(14,660

)

Interest expense - NCM (see Note 9)

 

$

(5,891

)

 

$

(4,782

)

Investment in NCM – receipt of common units (see Note 9)

 

$

3,620

 

 

$

1,552

 

Dividends accrued on unvested restricted stock unit awards

 

$

(256

)

 

$

(108

)

 

(1)

Additions to theatre properties and equipment included in accounts payable as of March 31, 2020 and December 31, 2019 were $17,260 and $14,991, respectively.

17.

Segments

The Company manages its international market and its U.S. market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues. The Company uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report total assets by segment because that information is not used to evaluate the performance of or allocate resources between segments.

25


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

Below is a breakdown of selected financial information by reportable operating segment:

 

 

 

 

Three Months Ended

 

 

 

 

March 31,

 

 

 

 

2020

 

 

2019

 

Revenues

 

 

 

 

 

 

 

 

 

U.S.

 

 

$

429,302

 

 

$

557,798

 

International

 

 

 

116,173

 

 

 

159,907

 

Eliminations

 

 

 

(1,859

)

 

 

(2,982

)

Total revenues

 

 

$

543,616

 

 

$

714,723

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

 

 

 

 

 

 

 

 

U.S.

 

 

$

56,072

 

 

$

125,759

 

International

 

 

 

10,139

 

 

 

26,495

 

Total Adjusted EBITDA

 

 

$

66,211

 

 

$

152,254

 

 

 

 

 

 

 

 

 

 

 

Capital expenditures

 

 

 

 

 

 

 

 

 

U.S.

 

 

$

25,673

 

 

$

52,339

 

International

 

 

 

8,470

 

 

 

5,230

 

Total capital expenditures

 

 

$

34,143

 

 

$

57,569

 

The following table sets forth a reconciliation of net income (loss) to Adjusted EBITDA:

 

 

 

Three Months Ended

 

 

 

 

March 31,

 

 

 

 

2020

 

 

2019

 

Net income (loss)

 

 

$

(59,422

)

 

$

33,193

 

Add (deduct):

 

 

 

 

 

 

 

 

 

Income taxes

 

 

 

(3,108

)

 

 

11,917

 

Interest expense (1)

 

 

 

24,666

 

 

 

25,141

 

Other (income) expense, net (2)

 

 

 

169

 

 

 

(8,335

)

Cash distributions from DCIP (3)

 

 

 

5,161

 

 

 

5,218

 

Cash distributions from other equity investees (4)

 

 

 

11,445

 

 

 

9,124

 

Depreciation and amortization

 

 

 

65,256

 

 

 

64,462

 

Impairment of long-lived assets

 

 

 

16,619

 

 

 

5,584

 

Loss on disposal of assets and other

 

 

 

1,905

 

 

 

3,799

 

Non-cash rent expense

 

 

 

(591

)

 

 

(819

)

Share based awards compensation expense

 

 

 

4,111

 

 

 

2,970

 

Adjusted EBITDA

 

 

$

66,211

 

 

$

152,254

 

 

 

(1)

Includes amortization of debt issue costs.

 

(2)

Includes interest income, foreign currency exchange gain (loss), equity in income of affiliates and interest expense - NCM and excludes distributions from NCM.

 

(3)

See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP, at Note 10. These distributions are reported entirely within the U.S. operating segment.

 

(4)

Includes cash distributions received from equity investees, other than those from DCIP noted above, that were recorded as a reduction of the respective investment balances (see Notes 9 and 10).  These distributions are reported entirely within the U.S. operating segment.

26


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

Financial Information About Geographic Areas

Below is a breakdown of selected financial information by geographic area:

 

 

 

 

Three Months Ended

 

 

 

 

March 31,

 

Revenues

 

 

2020

 

 

2019

 

U.S.

 

 

$

429,302

 

 

$

557,798

 

Brazil

 

 

 

52,968

 

 

 

70,861

 

Other international countries

 

 

 

63,205

 

 

 

89,046

 

Eliminations

 

 

 

(1,859

)

 

 

(2,982

)

Total

 

 

$

543,616

 

 

$

714,723

 

 

 

 

As of

 

 

As of

 

Theatre Properties and Equipment-net

 

March 31, 2020

 

 

December 31, 2019

 

U.S.

 

$

1,408,772

 

 

$

1,436,275

 

Brazil

 

 

86,474

 

 

 

118,367

 

Other international countries

 

 

163,079

 

 

 

180,605

 

Total

 

$

1,658,325

 

 

$

1,735,247

 

 

18.

Related Party Transactions

The Company manages theatres for Laredo Theatre, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell is the Company’s Chairman of the Board of Directors and directly and indirectly owns approximately 8% of the Company’s common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenues up to $50,000 and 3% of annual theatre revenues in excess of $50,000. The Company recorded $62 and $146 of management fee revenues during the three months ended March 31, 2020 and 2019, respectively. All such amounts are included in the Company’s condensed consolidated financial statements with the intercompany amounts eliminated in consolidation.

The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC (“Copper Beech”) to use, on occasion, a private aircraft owned by Copper Beech. Copper Beech is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech for the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip.  For the three months ended March 31, 2020 and 2019, the aggregate amounts paid to Copper Beech for the use of the aircraft was $12 and $7, respectively.

The Company leases 14 theatres and one parking facility from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of the Company’s directors and is an officer of the general partner of Syufy. Of these 15 leases, 14 have fixed minimum annual rent. The one lease without minimum annual rent has rent based upon a specified percentage of gross sales as defined in the lease. For the three months ended March 31, 2020 and 2019, the Company paid total rent of approximately $4,065 and $6,590, respectively, to Syufy.

The Company has a 50% voting interest in FE Concepts, a joint venture with AWSR, an entity owned by Lee Roy Mitchell and Tandy Mitchell.  FE Concepts operates a family entertainment center that offers bowling, gaming, movies and other amenities that opened during December 2019.  See Note 10 for further discussion. The Company has a theatre services agreement with FE Concepts under which the Company receives management fees for providing film booking and equipment monitoring services for the facility. The Company recorded $10 of management fees during the three months ended March 31, 2020.

 


27


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

19.

Commitments and Contingencies

From time to time, the Company is involved in various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, landlord-tenant disputes, patent claims and contractual disputes, some of which are covered by insurance. The Company believes its potential liability with respect to proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.  

Intertrust Technologies Corporation (“Intertrust”) v. Cinemark Holdings, Inc., Regal, AMC, et al.  This case was filed against the Company on August 7, 2019 in the Eastern District of Texas – Marshall Division alleging patent infringement. The Company firmly maintains that the contentions of the Plaintiff are without merit and will vigorously defend itself against the lawsuit. Although the Company does not believe that it has infringed on any of Intertrust’s patents, it cannot predict the outcome of this litigation.

Flagship Theatres of Palm Desert, LLC d/b/a Cinemas Palme D’Or v. Century Theatres, Inc., and Cinemark USA, Inc.; Superior Court of the State of California, County of Los Angeles.  Plaintiff in this case alleges that the Company violated California antitrust and unfair competition laws by engaging in “circuit dealing” with various motion picture distributors and tortiously interfered with Plaintiff’s business relationships.  Plaintiff seeks compensatory damages, trebling of those damages under California law, punitive damages, injunctive relief, attorneys’ fees, costs and interest.  Plaintiff also alleges that the Company’s conduct ultimately resulted in closure of its theatre in June 2016.  The Company denied the allegations.  In 2008, the Company moved for summary judgment on Plaintiff’s claims, arguing primarily that clearances between the theatres at issue were lawful and that Plaintiff lacked proof sufficient to support certain technical elements of its antitrust claims.  The trial court granted that motion and dismissed Plaintiff’s claims.  Plaintiff appealed and, in 2011, the Court of Appeal reversed, holding, among other things, that Plaintiff’s claims were not about the illegality of clearances but were focused, instead, on “circuit dealing.” Having re-framed the claims in that manner, the Court of Appeal held that the trial court’s decision to limit discovery to the market where the theatres at issue operated was an error, as “circuit dealing” necessarily involves activities in different markets.  Upon return to the trial court, the parties engaged in additional, broadened discovery related to Plaintiff’s “circuit dealing” claim.  Thereafter, the Company moved again for summary judgment on all of Plaintiff’s claims.  That new motion for summary judgment was pending when, on or about April 11, 2014, the trial court granted the Company’s motion for terminating sanctions and entered a judgment dismissing the case with prejudice.  Plaintiff then appealed that second dismissal, seeking to have the judgment reversed and the case remanded to the trial court.  The Court of Appeal issued a ruling on May 24, 2016, reversing the granting of terminating sanctions and instead imposed a lesser evidentiary and damages preclusion sanction.  The case returned to the trial court on October 6, 2016.  On May 10, 2018, after a five-week jury trial, the jury found no liability on one circuit dealing claim and awarded Plaintiff damages on the other claim, which are tripled for antitrust damage awards.  Plaintiff would also be entitled to certain court costs and to seek at least some portion of its attorney’s fees.  During 2018, the Company recorded a litigation reserve based on the jury award, court costs and attorney’s fees.  The trial court denied a motion for a judgment notwithstanding the verdict and a motion for a new trial. The Company has appealed the judgment.  Although the Company denies that it engaged in any form of circuit dealing, it cannot predict the outcome of its pending motions or future appeals.

Civil Investigative Demand. The Company received a Civil Investigative Demand (“CID”) from the Antitrust Division of the United States Department of Justice. The CID relates to an investigation under Sections 1 and 2 of the Sherman Act. The Company also received CIDs from the Antitrust Section of the Office of the Attorney General of the State of Ohio and later from other states regarding similar inquiries under state antitrust laws. The CIDs request the Company to answer interrogatories, and produce documents, or both, related to the investigation of matters including film clearances, potential coordination and/or communication with other major theatre circuits and related joint ventures.  The Company intends to fully cooperate with all federal and state government agencies. Although the Company does not believe that it has violated any federal or state antitrust or competition laws, it cannot predict the ultimate scope, duration or outcome of these investigations.

20.

Subsequent Events

On April 20, 2020, the Company issued $250,000 8.750% senior secured notes (the “8.750% Secured Notes”).  The notes will mature on May 1, 2025; provided, however, that if (i) on September 13, 2022, the aggregate outstanding principal amount of the 5.125% Senior Notes that shall not have been purchased, repurchased, redeemed, defeased or otherwise acquired, retired, cancelled or discharged exceeds $50,000, the notes will mature on September 14, 2022 and (ii) on February 27, 2023, the aggregate outstanding principal amount of the 4.875% Senior Notes that shall not have been purchased, repurchased, redeemed, defeased or otherwise acquired, retired, cancelled or discharged exceeds $50,000, the notes will mature on February 28, 2023. Interest on the notes will be payable on May 1 and November 1 of each year, beginning on November 1, 2020.  

The 8.750% Secured Notes will be fully and unconditionally guaranteed on a joint and several senior basis by certain of the Company’s subsidiaries that guarantee, assume or in any other manner become liable with respect to any of the Company’s or its guarantors’ other debt. If the Company cannot make payments on the 8.750% Secured Notes when they are due, the Company’s

28


CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

 

guarantors must make them instead. Under certain circumstances, the guarantees may be released without action by, or the consent of, the holders of the 8.750% Secured Notes.

The 8.750% Secured Notes and the guarantees will be the Company’s and its guarantors’ senior obligations and they will:

 

rank effectively senior in right of payment to the Company’s and its guarantors’ existing and future debt that is not secured by the collateral as described within the indentures to the 8.750% Secured Notes (“Collateral”), including all obligations under the Credit Agreement, and unsecured obligations, including the existing senior notes, in each case to the extent of the value of the collateral;

 

rank effectively junior to the Company’s and its guarantors’ existing and future debt secured by assets that are not part of the Collateral to the extent of the value of the collateral securing such debt, including all obligations under the Credit Agreement;

 

otherwise rank equally in right of payment to the Company’s and its guarantors’ existing and future senior debt, including debt under the Credit Agreement and the existing senior notes;

 

rank senior in right of payment to the Company’s and its guarantors’ future subordinated debt; and

 

be structurally subordinated to all existing and future debt and other liabilities of the Company’s non-guarantor subsidiaries.

The indenture to the 8.750% Secured Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. Upon a change of control, as defined in the indenture governing the 8.750% Secured Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 8.750% Secured Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 8.750% Secured Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies a coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances.

On April 20, 2020, in conjunction with the issuance of the 8.750% Secured Notes, the Company obtained a waiver of the maintenance covenant from the majority of revolving lenders under the Credit Agreement for the fiscal quarters ending September 30, 2020 and December 31, 2020.

 

 

29


 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and related notes and schedules included elsewhere in this report.

We are a leader in the motion picture exhibition industry, with theatres in the U.S., Brazil, Argentina, Chile, Colombia, Ecuador, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. As of March 31, 2020, we managed our business under two reportable operating segments – U.S. markets and international markets. See Note 17 to our condensed consolidated financial statements.

We generate revenues primarily from filmed entertainment box office receipts and concession sales with additional revenues from screen advertising sales and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals and electronic video games located in some of our theatres. We also offer alternative entertainment, such as live and pre-recorded sports programs, concert events, the Metropolitan Opera, in-theatre gaming and other special events in our theatres through AC JV, LLC. NCM provides our domestic theatres with various forms of in-theatre advertising. Our Flix Media subsidiaries provide screen advertising and alternative content for our international circuit and to other international exhibitors.

Films leading the box office during the three months ended March 31, 2020 included Bad Boys for Life, 1917, Sonic the Hedgehog, Jumanji: The Next Level, Star Wars: Episode IX – The Rise of Skywalker, Birds of Prey, Dolittle, Little Women, The Invisible Man and The Call of the Wild. Films scheduled for release during the remainder of 2020 include Wonder Woman 1984, No Time To Die, Mulan, Black Widow, A Quiet Place: Part 2, Top Gun: Maverick, Tenet, and The King’s Man, among other films.

Film rental costs are variable in nature and fluctuate with our admissions revenues. Film rental costs as a percentage of revenues are generally higher for periods in which more blockbuster films are released. The Company also receives virtual print fees from studios for certain of its international locations, which are included as a contra-expense in film rentals and advertising costs.  Advertising costs, which are expensed as incurred, are primarily related to campaigns for new and renovated theatres, loyalty and membership programs and brand advertising that vary depending on the timing of such campaigns.

Concession supplies expense is variable in nature and fluctuates with our concession revenues and product mix. We negotiate prices for concession supplies directly with concession vendors and manufacturers to obtain volume rates.

Although salaries and wages include a fixed cost component (i.e. the minimum staffing costs to operate a theatre facility during non-peak periods), salaries and wages move in relation to revenues as theatre staffing is adjusted to respond to changes in attendance. In some international locations, staffing levels are also subject to local regulations.

Facility lease expense is primarily a fixed cost at the theatre level as most of our facility leases require a fixed monthly minimum rent payment. Certain leases are subject to percentage rent only, while others are subject to percentage rent in addition to their fixed monthly rent if a target annual performance level is achieved. Facility lease expense as a percentage of revenues is also affected by the number of theatres under operating leases, the number of theatres under capital and finance leases and the number of owned theatres.

Utilities and other costs include both fixed and variable costs and primarily consist of utilities, expenses for projection and sound equipment maintenance and monitoring, credit card fees, third party ticket sales commissions, property taxes, janitorial costs, repairs, maintenance and security services.

General and administrative expenses are primarily fixed in nature and consist of the costs to support the overall management of the Company, including salaries and wages, incentive compensation and benefit costs for our corporate office personnel, facility expenses for our corporate offices, consulting fees, legal fees, audit fees, supplies and other costs that are not specifically associated with the operations of our theatres.

Recent Developments

Impact of COVID-19

The recent outbreak of the COVID-19 pandemic has had an unprecedented impact on the world and the movie exhibition industry. The situation continues to be volatile and the social and economic effects are widespread. As a movie exhibitor that operates spaces where patrons gather in close proximity, our business is significantly impacted by protective actions that federal, state and local governments have taken to control the spread of the pandemic. These actions include, among other things, encouragement of social

30


 

distancing, restrictions on freedom of movement, business closures, quarantines, and shelter-in-place and stay-at-home orders. As a result of these measures, we temporarily closed all of our theatres in the U.S. and Latin America effective March 18, 2020.

We believe we have sufficient cash to sustain our operations for the remainder of the year, even if our theatres remained closed for the remainder of the year.  Nonetheless, the COVID-19 pandemic has had and may continue to have adverse effects on our business, results of operations, cash flows, financial condition, access to credit markets.  In light of the COVID-19 pandemic, we have been working to preserve cash and ensure sufficient liquidity to endure the impacts of the global crisis, even if prolonged.   Some of the actions taken by us include the following:

 

our directors and chief executive officer have elected to take no salary, and many of our executives have voluntarily reduced their salaries by 80% while our theatres remain closed;

 

halted all non-essential operating and capital expenditures, such as marketing promotions and initiatives, travel and entertainment, system enhancements and related consulting projects, recliner conversions, XD expansions and certain other theatre enhancements, which will significantly reduce utilities and other costs, general and administrative expenses and capital expenditures on a temporary basis;

 

suspended the quarterly dividend;

 

implemented a formal daily review and approval process by our chief financial officer for all outgoing procurement and payment requests;

 

laid off over 17,500 domestic hourly theatre employees, furloughed 50% of headquarter employees at 20% of salary (with full benefits) and reduced salaries of remaining employees by 50% and pursued similar actions in international markets to the extent permitted by local laws; which will significantly reduce salaries and wages expenses and general administrative expenses while theatres are closed; and

 

started working actively with landlords and major suppliers to modify the timing of certain contractual payments.

We continue to evaluate the impact of certain tax-related benefits available under the Cares Act, which, among other things, includes provisions relating to refundable payroll tax credits, deferment of employer social security payments, NOL utilization and carryback periods, modifications to the net interest deduction limitations and a technical correction to the 2017 Tax Cuts and Jobs Act, which makes certain qualified improvement property eligible for bonus depreciation.  Based upon a review of the Cares Act, we expect to:

 

receive an approximately $20 million cash tax refund in 2020 related to qualified improvement property expenditures from 2018 and 2019;

 

benefit from the ability to defer social security payroll tax matches that would otherwise be required in 2020;

 

receive a payroll tax credit in 2020 for expenses related to paying wages and health benefits to employees who are not working as a result of closures and reduced receipts associated with COVID-19; and

 

apply any tax loss incurred in 2020 to prior year income for a refund when our 2020 tax return is filed.

We continue to review, and intend to seek, other available potential benefits under the Cares Act as well as any future legislation signed into law during 2020.

Issuance of 8.750% Senior Secured Notes

On April 20, 2020, we issued $250 million 8.750% senior secured notes (the “8.750% Secured Notes”).  The notes will mature on May 1, 2025; provided, however, that if (i) on September 13, 2022, the aggregate outstanding principal amount of the 5.125% Senior Notes that shall not have been purchased, repurchased, redeemed, defeased or otherwise acquired, retired, cancelled or discharged exceeds $50 million, the notes will mature on September 14, 2022 and (ii) on February 27, 2023, the aggregate outstanding principal amount of the 4.875% Senior Notes that shall not have been purchased, repurchased, redeemed, defeased or otherwise acquired, retired, cancelled or discharged exceeds $50 million, the notes will mature on February 28, 2023. Interest on the notes will be payable on May 1 and November 1 of each year, beginning on November 1, 2020.  

The 8.750% Secured Notes will be fully and unconditionally guaranteed on a joint and several senior basis by certain of our subsidiaries that guarantee, assume or in any other manner become liable with respect to any of our or our guarantors’ other debt. If we cannot make payments on the 8.750% Secured Notes when they are due, our guarantors must make them instead. Under certain circumstances, the guarantees may be released without action by, or the consent of, the holders of the 8.750% Secured Notes.

The 8.750% Secured Notes and the guarantees will be ours and our guarantors’ senior obligations and they will:

 

rank effectively senior in right of payment to our and our guarantors’ existing and future debt that is not secured by the collateral as described within the indentures to the 8.750% Secured Notes (“Collateral”), including all obligations under

31


 

 

the Credit Agreement, and unsecured obligations, including the existing senior notes, in each case to the extent of the value of the collateral;

 

rank effectively junior to our and our guarantors’ existing and future debt secured by assets that are not part of the Collateral to the extent of the value of the collateral securing such debt, including all obligations under the Credit Agreement;

 

otherwise rank equally in right of payment to our and our guarantors’ existing and future senior debt, including debt under the Credit Agreement and the existing senior notes;

 

rank senior in right of payment to our and our guarantors’ future subordinated debt; and

 

be structurally subordinated to all existing and future debt and other liabilities of our non-guarantor subsidiaries.

The indenture to the 8.750% Secured Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. Upon a change of control, as defined in the indenture governing the 8.750% Secured Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 8.750% Secured Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 8.750% Secured Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies a coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances.

On April 20, 2020, in conjunction with the issuance of the 8.750% Secured Notes, we obtained a waiver of the maintenance covenant from the majority of revolving lenders under the Credit Agreement for the fiscal quarters ending September 30, 2020 and December 31, 2020.

 


32


 

Results of Operations

The following table sets forth, for the periods indicated, certain operating data and the percentage of revenues represented by certain items reflected in our condensed consolidated statements of income.

 

 

 

 

Three Months Ended

 

 

 

 

March 31,

 

 

 

 

2020

 

 

2019

 

Operating data (in millions):

 

 

 

 

 

 

 

 

 

Revenues

 

 

 

 

 

 

 

 

 

Admissions

 

 

$

292.5

 

 

$

395.5

 

Concession

 

 

 

190.4

 

 

 

251.3

 

Other

 

 

 

60.7

 

 

 

67.9

 

Total revenues

 

 

$

543.6

 

 

$

714.7

 

Cost of operations

 

 

 

 

 

 

 

 

 

Film rentals and advertising

 

 

 

156.6

 

 

 

210.1

 

Concession supplies

 

 

 

34.8

 

 

 

43.1

 

Salaries and wages

 

 

 

87.6

 

 

 

96.1

 

Facility lease expense

 

 

 

82.2

 

 

 

85.6

 

Utilities and other

 

 

 

100.5

 

 

 

110.6

 

General and administrative expenses

 

 

 

41.0

 

 

 

38.0

 

Depreciation and amortization

 

 

 

65.3

 

 

 

64.5

 

Impairment of long-lived assets

 

 

 

16.6

 

 

 

5.6

 

Loss on disposal of assets and other

 

 

 

1.9

 

 

 

3.8

 

Total cost of operations

 

 

 

586.5

 

 

 

657.4

 

Operating income (loss)

 

 

$

(42.9

)

 

$

57.3

 

 

 

 

 

 

 

 

 

 

 

Operating data as a percentage of total revenues:

 

 

 

 

 

 

 

 

 

Revenues

 

 

 

 

 

 

 

 

 

Admissions

 

 

 

53.8

%

 

 

55.3

%

Concession

 

 

 

35.0

%

 

 

35.2

%

Other

 

 

 

11.2

%

 

 

9.5

%

Total revenues

 

 

 

100.0

%

 

 

100.0

%

Cost of operations (1)

 

 

 

 

 

 

 

 

 

Film rentals and advertising

 

 

 

53.5

%

 

 

53.1

%

Concession supplies

 

 

 

18.3

%

 

 

17.2

%

Salaries and wages

 

 

 

16.1

%

 

 

13.4

%

Facility lease expense

 

 

 

15.1

%

 

 

12.0

%

Utilities and other

 

 

 

18.5

%

 

 

15.5

%

General and administrative expenses

 

 

 

7.5

%

 

 

5.3

%

Depreciation and amortization

 

 

 

12.0

%

 

 

9.0

%

Impairment of long-lived assets

 

 

 

3.1

%

 

 

0.8

%

Loss on disposal of assets and other

 

 

 

0.3

%

 

 

0.5

%

Total cost of operations

 

 

 

107.9

%

 

 

92.0

%

Operating income (loss)

 

 

 

(7.9

)%

 

 

8.0

%

Average screen count (month end average)

 

 

 

6,139

 

 

 

6,044

 

Total revenues per average screen (dollars)

 

 

$

88,551

 

 

$

118,253

 

 

(1)

All costs are expressed as a percentage of total revenues, except film rentals and advertising, which are expressed as a percentage of admissions revenues and concession supplies, which are expressed as a percentage of concession revenues.

33


 

Three months ended March 31, 2020 versus March 31, 2019

Revenues. All of our domestic theatres were temporarily closed effective March 17, 2020 and all of our international theatres were temporarily closed effective March 18, 2020 as a result of the COVID-19 pandemic.  See further discussion at Recent Developments and Note 2 of our condensed consolidated financial statements.  Total revenues decreased $171.1 million to $543.6 million for the three months ended March 31, 2020 (“first quarter of 2020”) from $714.7 million for the three months ended March 31, 2019 (“first quarter of 2019”). The table below, presented by reportable operating segment, summarizes our revenue performance and certain key performance indicators for the three months ended March 31, 2020 and 2019.

 

 

U.S. Operating Segment

 

 

International Operating Segment

 

 

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Constant

Currency (3)

 

 

 

 

 

 

 

 

 

 

 

 

 

2020

 

2019

 

%

Change

 

 

2020

 

2019

 

%

Change

 

 

2020

 

%

Change

 

 

2020

 

2019

 

%

Change

 

Admissions revenues (1)

 

$

232.3

 

$

308.8

 

 

(24.8

)%

 

$

60.2

 

$

86.7

 

 

(30.6

)%

 

$

71.1

 

 

(18.0

)%

 

$

292.5

 

$

395.5

 

 

(26.0

)%

Concession revenues (1)

 

$

152.8

 

$

199.4

 

 

(23.4

)%

 

$

37.6

 

$

51.9

 

 

(27.6

)%

 

$

43.7

 

 

(15.8

)%

 

$

190.4

 

$

251.3

 

 

(24.2

)%

Other revenues (1)(2)

 

$

42.3

 

$

46.6

 

 

(9.2

)%

 

$

18.4

 

$

21.3

 

 

(13.6

)%

 

$

22.6

 

 

6.1

%

 

$

60.7

 

$

67.9

 

 

(10.6

)%

Total revenues (1)(2)

 

$

427.4

 

$

554.8

 

 

(23.0

)%

 

$

116.2

 

$

159.9

 

 

(27.3

)%

 

$

137.4

 

 

(14.1

)%

 

$

543.6

 

$

714.7

 

 

(23.9

)%

Attendance (1)

 

 

27.9

 

 

38.7

 

 

(27.9

)%

 

 

17.9

 

 

23.6

 

 

(24.2

)%

 

 

 

 

 

 

 

 

 

45.8

 

 

62.3

 

 

(26.5

)%

Average ticket price (1)

 

$

8.33

 

$

7.98

 

 

4.4

%

 

$

3.36

 

$

3.67

 

 

(8.4

)%

 

$

3.97

 

 

8.2

%

 

$

6.39

 

$

6.35

 

 

0.6

%

Concession revenues per patron (1)

 

$

5.48

 

$

5.15

 

 

6.4

%

 

$

2.10

 

$

2.20

 

 

(4.5

)%

 

$

2.44

 

 

10.9

%

 

$

4.16

 

$

4.03

 

 

3.2

%

 

(1)

Revenues and attendance amounts in millions.  Average ticket price is calculated as admissions revenues divided by attendance.  Concession revenues per patron is calculated as concession revenues divided by attendance.  

(2)

U.S. operating segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 17 to our condensed consolidated financial statements.

(3)

Constant currency revenue amounts, which are non-GAAP measurements, were calculated using the average exchange rate for the corresponding month for 2019. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time in accordance with U.S. GAAP. Significant changes in foreign currency exchange rates from one period to the next can result in meaningful variations in reported results.   We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance that excludes the impact of foreign currency fluctuations.

 

U.S. Admissions revenues decreased $76.5 million primarily due to a 27.9% decrease in attendance, partially offset by a 4.4% increase in average ticket price. The increase in average ticket price was primarily due to price increases, partially offset by the impact of the deferral of admissions revenues for loyalty points issued. Concession revenues decreased $46.6 million primarily due to the 27.9% decrease in attendance, partially offset by a 6.4% increase in concession revenues per patron. Concession revenues per patron grew primarily due to incremental sales of traditional concession products, continued expansion of concession offerings and price increases. Attendance declined primarily due to the temporary closure of all of our U.S. theatres on March 17, 2020.  Other revenues decreased $4.3 million as a result of the temporary closure of theatres.  

 

International. Admissions revenues decreased $26.5 million as reported ($15.6 million in constant currency). Average ticket price decreased 8.4% as reported (increased 8.2% in constant currency). Concession revenues decreased $14.3 million as reported ($8.2 million in constant currency). Concession revenues per patron decreased by 4.5% as reported (increased 10.9% in constant currency). Average ticket price and concession revenues per patron decreased, as reported, primarily due to the impact of changes in foreign currency exchange rates in certain countries in which we operate, partially offset by price increases.  Attendance declined primarily due to the temporary closure of all of our international theatres on March 18, 2020.  

Cost of Operations. The table below summarizes our theatre operating costs (in millions) by reportable operating segment for the three months ended March 31, 2020 and 2019.

 

 

U.S. Operating Segment

 

 

International Operating Segment

 

 

Consolidated

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

Constant

Currency (1)

2020

 

 

2020

 

 

2019

 

Film rentals and advertising

 

$

128.0

 

 

$

169.2

 

 

$

28.6

 

 

$

40.9

 

 

$

33.9

 

 

$

156.6

 

 

$

210.1

 

Concession supplies

 

$

25.6

 

 

$

32.0

 

 

$

9.2

 

 

$

11.1

 

 

$

10.9

 

 

$

34.8

 

 

$

43.1

 

Salaries and wages

 

$

71.2

 

 

$

76.8

 

 

$

16.4

 

 

$

19.3

 

 

$

19.6

 

 

$

87.6

 

 

$

96.1

 

Facility lease expense

 

$

65.4

 

 

$

64.9

 

 

$

16.8

 

 

$

20.7

 

 

$

19.3

 

 

$

82.2

 

 

$

85.6

 

Utilities and other

 

$

75.0

 

 

$

79.8

 

 

$

25.5

 

 

$

30.8

 

 

$

30.2

 

 

$

100.5

 

 

$

110.6

 

 

(1)

Constant currency expense amounts, which are non-GAAP measurements were calculated using the average exchange rate for the corresponding month for 2019. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time in accordance with U.S. GAAP. Significant changes in foreign currency exchange rates from one period to the next can result in meaningful variations in reported results. We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance that excludes the impact of foreign currency fluctuations.

34


 

 

U.S. Film rentals and advertising costs were $128.0 million, or 55.1% of admissions revenues, for the first quarter of 2020 compared to $169.2 million, or 54.8% of admissions revenues, for the first quarter of 2019. Concession supplies expense was $25.6 million, or 16.8% of concession revenues, for the first quarter of 2020 compared to $32.0 million, or 16.0% of concession revenues, for the first quarter of 2019.  The increase in the concession supplies rate was primarily due to expanded food and beverage offerings and the impact of disposing perishable food as a result of temporarily closing our theatres.

Salaries and wages decreased to $71.2 million for the first quarter of 2020 from $76.8 million for the first quarter of 2019 primarily due to the temporary closure of all of our U.S. theatres on March 17, 2020. Facility lease expense increased to $65.4 million for the first quarter of 2020 from $64.9 million for the first quarter of 2019 primarily due to new theatres. Utilities and other costs decreased to $75.0 million for the first quarter of 2020 from $79.8 million for the first quarter of 2019 due to the temporary closure of all of our U.S. theatres on March 17, 2020 which resulted in lower revenues and lower credit card fees and third party ticket sales commissions.

 

International. Film rentals and advertising costs were $28.6 million ($33.9 million in constant currency), or 47.5% of admissions revenues, for the first quarter of 2020 compared to $40.9 million, or 47.2% of admissions revenues, for the first quarter of 2019. Concession supplies expense was $9.2 million ($10.9 million in constant currency), or 24.5% of concession revenues, for the first quarter of 2020 compared to $11.1 million, or 21.4% of concession revenues, for the first quarter of 2019.  The increase in the concession supplies rate was primarily due to expanded food and beverage offerings and the impact of disposing perishable food as a result of temporarily closing our theatres.

Salaries and wages decreased to $16.4 million (increased to $19.6 million in constant currency) for the first quarter of 2020 compared to $19.3 million for the first quarter of 2019.  The increase in constant currency was due to new theatres, partially offset by decreased attendance due to the temporary closure of all of our international theatres on March 18, 2020. Facility lease expense decreased to $16.8 million ($19.3 million in constant currency) for the first quarter of 2020 compared to $20.7 million for the first quarter of 2019. The decrease was due to lower percentage rent due to the temporary closure of all of our international theatres on March 18, 2020. Utilities and other costs decreased to $25.5 million ($30.2 million in constant currency) for the first quarter of 2020 compared to $30.8 million for the first quarter of 2019 due to the temporary closure of all of our international theatres on March 18, 2020 which resulted in lower revenues and lower credit card fees and third party ticket sales commissions, as well as lower 3D glasses expenses, partially offset by an increase in utilities expense.

General and Administrative Expenses.  General and administrative expenses increased to $41.0 million for the first quarter of 2020 from $38.0 million for the first quarter of 2019. The increase was primarily due to inflation, increases in salaries and incentive compensation and increased cloud-based software costs, which were partially offset by the impact of changes in foreign currency exchange rates in certain countries in which we operate.

Depreciation and Amortization. Depreciation and amortization expense increased to $65.3 million during the first quarter of 2020 compared to $64.5 million during the first quarter of 2019. The increase was primarily due to new theatres.

Impairment of Long-Lived Assets.  We recorded asset impairment charges on assets held and used of $16.6 million during the first quarter of 2020 compared to $5.6 million during the first quarter of 2019. The long-lived asset impairment charges recorded during each of the periods presented were specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatre. The long-lived asset impairment charges recorded during the first quarter of 2020 were also impacted by the temporary closure of our theatres and the associated assumptions related to estimated future cash flows.  Impairment charges for the first quarter of 2020 impacted eight countries and impairment charges for the first quarter of 2019 impacted two countries.  See Note 13 to our condensed consolidated financial statements.

Loss on Disposal of Assets and Other. We recorded a loss on disposal of assets and other of $1.9 million during the first quarter of 2020 compared to $3.8 million during the first quarter of 2019. Activity for the first quarter of 2020 and 2019 was primarily due to the retirement of assets related to theatre remodels.

Interest Expense.  Interest costs incurred, including amortization of debt issue costs, were $25.0 million during the first quarter of 2020 compared to $25.1 million during the first quarter of 2019.

Distributions from NCM.  We recorded distributions from NCM of $5.2 million during the first quarter of 2020 compared to $4.5 million recorded during the first quarter of 2019, which were in excess of the carrying value of our Tranche 1 investment. See Note 9 to our condensed consolidated financial statements.  

35


 

Interest expense – NCM.  We recorded non-cash interest expense of $5.9 million for the first quarter of 2020 compared to $4.8 million recorded during the first quarter of 2019, related to the significant financing component associated with certain of our agreements with NCM.  See Note 9 to our condensed consolidated financial statements for further discussion.  

Equity in Income of Affiliates. We recorded equity in income of affiliates of $8.5 million during the first quarter of 2020 compared to $10.4 million during the first quarter of 2019. See Notes 9 and 10 to our condensed consolidated financial statements for information about our equity investments.

Income Taxes. An income tax benefit of $3.1 million was recorded for the first quarter of 2020 compared to income tax expense of $11.9 million for the first quarter of 2019. The effective tax rate was approximately 4.97% for the first quarter of 2020 compared to 26.42% for the first quarter of 2019. The income tax provision for the three months ended March 31, 2020 was unfavorably impacted by $16.1 million of net discrete tax charges, including a $5.2 million charge related to a valuation allowance recorded against certain foreign net deferred tax assets in Colombia and Central America and $10.7 million related to the remeasurement of deferred tax balances due to a projected net operating loss carryback.  Income tax provisions for interim (quarterly) periods are based on estimated annual income tax rates and are adjusted for the effects of significant, infrequent or unusual items (i.e. discrete items) occurring during the interim period. As a result, the interim rate may vary significantly from the normalized annual rate.

Liquidity and Capital Resources

Operating Activities

We primarily collect our revenues in cash, mainly through box office receipts and the sale of concessions. Our revenues are received in cash prior to the payment of related expenses, therefore we have an operating “float” and historically have not required traditional working capital financing. However, we temporarily closed all of our theatres effective March 18, 2020 as discussed above in Recent Developments and will fund operating expenses while our theatres are closed with cash on hand and additional financing discussed below under Financing Activities. Cash used for operating activities was $15.6 million for the three months ended March 31, 2020 compared to cash provided by operating activities of $104.3 million for the three months ended March 31, 2019. The decrease in cash provided by operating activities was primarily due to the Company’s net loss as a result of the temporary closure of all of our theatres effective March 18, 2020 and the level and timing of payments to suppliers during each respective period.  

Investing Activities

Our investing activities have been principally related to the development, remodel and acquisition of theatres. New theatre openings and acquisitions historically have been financed with internally generated cash and by debt financing, including borrowings under our senior secured credit facility. Cash used for investing activities was $34.1 million for the three months ended March 31, 2020 compared to $57.5 million for the three months ended March 31, 2019.

Capital expenditures for the three months ended March 31, 2020 and 2019 were as follows (in millions):

 

Period

 

New Theatres

 

 

Existing Theatres

 

 

Total

 

Three Months Ended March 31, 2020

 

$

8.1

 

 

$

26.0

 

 

$

34.1

 

Three Months Ended March 31, 2019

 

$

15.0

 

 

$

42.6

 

 

$

57.6

 

We operated 555 theatres with 6,145 screens worldwide as of March 31, 2020.  Theatres and screens acquired, built and closed during the three months ended March 31, 2020 were as follows:

 

 

January 1, 2020

 

 

Built

 

 

Closed

 

 

March 31, 2020

 

U.S

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Theatres

 

 

345

 

 

 

1

 

 

 

1

 

 

 

345

 

Screens

 

 

4,645

 

 

 

12

 

 

 

8

 

 

 

4,649

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

International

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Theatres

 

 

209

 

 

 

1

 

 

 

 

 

 

210

 

Screens

 

 

1,487

 

 

 

9

 

 

 

 

 

 

1,496

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Worldwide

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Theatres

 

 

554

 

 

 

2

 

 

 

1

 

 

 

555

 

Screens

 

 

6,132

 

 

 

21

 

 

 

8

 

 

 

6,145

 

 


36


 

As of March 31, 2020, we had the following signed commitments (costs in millions):

 

 

Theatres

 

 

Screens

 

 

Estimated Cost

 

Remainder of 2020

 

 

 

 

 

 

 

 

 

 

 

 

U.S.

 

 

3

 

 

 

30

 

 

$

24

 

International

 

 

2

 

 

 

18

 

 

$

5

 

Total

 

 

5

 

 

 

48

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Subsequent to 2020

 

 

 

 

 

 

 

 

 

 

 

 

U.S.

 

 

9

 

 

 

112

 

 

$

79

 

International

 

 

8

 

 

 

63

 

 

$

35

 

Total

 

 

17

 

 

 

175

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total commitments at March 31, 2020

 

 

22

 

 

 

223

 

 

$

143

 

Actual expenditures for continued theatre development, remodels and acquisitions are subject to change based upon the availability of attractive opportunities.  We plan to fund capital expenditures for our continued development with cash flow from operations, borrowings under our senior secured credit facility, and proceeds from debt issuances, sale leaseback transactions and/or sales of excess real estate.

Financing Activities

Cash provided by financing activities was $48.0 million for the three months ended March 31, 2020 compared to cash used for financing activities of $47.9 million for the three months ended March 31, 2019.  The increase in cash provided by financing activities was primarily due to the $98.8 million proceeds from borrowings on the Company’s revolving credit line.

We, at the discretion of the board of directors and subject to applicable law, may pay dividends on our common stock. The amount, if any, of the dividends to be paid in the future will depend upon our then available cash balance, anticipated cash needs, overall financial condition, loan agreement restrictions as discussed below, future prospects for earnings and cash flows, as well as other relevant factors.  As discussed above in Recent Developments, we have suspended our quarterly dividend due to the impact of the COVID-19 pandemic.

We may from time to time, subject to compliance with our debt instruments, purchase our debt securities on the open market depending upon the availability and prices of such securities. Long-term debt consisted of the following as of March 31, 2020 (in millions):

 

Cinemark USA, Inc. term loan

 

$

644.7

 

Cinemark USA, Inc. revolving line of credit

 

 

98.8

 

Cinemark USA, Inc. 5.125% senior notes due 2022

 

 

400.0

 

Cinemark USA, Inc. 4.875% senior notes due 2023

 

 

755.0

 

Total long-term debt

 

$

1,898.5

 

Less current portion

 

 

6.6

 

Subtotal long-term debt, less current portion

 

$

1,891.9

 

Less:  Debt discounts and debt issuance costs, net of accumulated amortization

 

 

22.1

 

Long-term debt, less current portion, net of debt issuance costs

 

$

1,869.8

 

 

As of March 31, 2020, approximately $0.1 million was available for borrowing under the revolving line of credit after giving effect to a $1.1 million letter of credit outstanding.  

Contractual Obligations

There have been no material changes in our contractual obligations previously disclosed in “Liquidity and Capital Resources” in our Annual Report on Form 10-K for the year ended December 31, 2019 filed February 21, 2020.

37


 

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

Senior Secured Credit Facility

Cinemark USA, Inc. has a senior secured credit facility that includes a $700.0 million term loan and a $100.0 million revolving credit line (the “Credit Agreement”). Under the amended Credit Agreement, quarterly principal payments of $1.6 million are due on the term loan through December 31, 2024, with a final principal payment of $613.4 million due on March 29, 2025. After giving effect to a letter of credit outstanding as of March 31, 2020, Cinemark USA, Inc. had no available borrowing capacity on the revolving credit line.

Interest on the term loan accrues at Cinemark USA, Inc.’s option at: (A) the base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin of 0.75% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 1.75% per annum. Interest on the revolving credit line accrues, at our option, at: (A) a base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin that ranges from 0.50% to 1.25% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50% to 2.25% per annum. The margin of the revolving credit line is determined by the consolidated net senior secured leverage ratio as defined in the Credit Agreement.  

Cinemark USA, Inc.’s obligations under the Credit Agreement are guaranteed by Cinemark Holdings, Inc. and certain of Cinemark USA, Inc.’s domestic subsidiaries and are secured by mortgages on certain fee and leasehold properties and security interests in substantially all of Cinemark USA, Inc.’s and the guarantors’ personal property, including, without limitation, pledges of all of Cinemark USA, Inc.’s capital stock, all of the capital stock of certain of Cinemark USA, Inc.’s domestic subsidiaries and 65% of the voting stock of certain of its foreign subsidiaries.

The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on Cinemark USA, Inc.’s ability, and in certain instances, its subsidiaries’ and our ability, to consolidate or merge or liquidate, wind up or dissolve; substantially change the nature of its business; sell, transfer or dispose of assets; create or incur indebtedness; create liens; pay dividends or repurchase stock; and make capital expenditures and investments. If Cinemark USA, Inc. has borrowings outstanding on the revolving credit line, it is required to satisfy a consolidated net senior secured leverage ratio covenant as defined in the Credit Agreement, not to exceed 4.25 to 1.  As of March 31, 2020, the actual ratio was approximately 0.72 to 1.

The dividend restriction contained in the Credit Agreement prevents the Company and any of its subsidiaries from paying a dividend or otherwise distributing cash to its stockholders unless (1) the Company is not in default, and the distribution would not cause Cinemark USA, Inc. to be in default, under the Credit Agreement; and (2) the aggregate amount of certain dividends, distributions, investments, redemptions and capital expenditures made since December 18, 2012, including dividends declared by the board of directors, is less than the sum of (a) the aggregate amount of cash and cash equivalents received by Cinemark Holdings, Inc. or Cinemark USA, Inc. as common equity since December 18, 2012, (b) Cinemark USA, Inc.’s consolidated EBITDA minus 1.75 times its consolidated interest expense, each as defined in the Credit Agreement, and (c) certain other defined amounts. As of March 31, 2020, Cinemark USA, Inc. could have distributed up to approximately $3,227 million to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the Credit Agreement, subject to its available cash and other borrowing restrictions outlined in the agreement.  

We have four interest rate swap agreements that are used to hedge a portion of the interest rate risk associated with the variable interest rates on the term loan outstanding under the Credit Agreement. See Note 7 of our condensed consolidated financial statements for discussion of the interest rate swaps.

At March 31, 2020, there was $644.7 million outstanding under the term loan, $98.8 million of borrowings were outstanding under the $100.0 million revolving line of credit and approximately $0.1 million was available for borrowing under the revolving credit line after giving effect to a $1.1 million letter of credit outstanding.  On April 3, 2020, the letter of credit was cancelled and was no longer outstanding.   The average interest rate on outstanding term loan borrowings under the Credit Agreement at March 31, 2020 was approximately 3.5% per annum, after giving effect to the interest rate swap agreements discussed above.  The average interest rate on the outstanding revolver borrowings was 2.9% at March 31, 2020.

Cinemark USA, Inc. 5.125% Senior Notes

On December 18, 2012, Cinemark USA, Inc. issued $400.0 million aggregate principal amount of 5.125% Senior Notes due 2022, at par value (the “5.125% Senior Notes”). Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year. The 5.125% Senior Notes mature on December 15, 2022.

38


 

The indenture to the 5.125% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of March 31, 2020, Cinemark USA, Inc. could have distributed up to approximately $3,373 million to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 5.125% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. Upon a change of control, as defined in the indenture governing the 5.125% Senior Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 5.125% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 5.125% Senior Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of March 31, 2020 was approximately 6.6 to 1.

Cinemark USA, Inc. 4.875% Senior Notes

On May 24, 2013, Cinemark USA, Inc. issued $530.0 million aggregate principal amount of 4.875% Senior Notes due 2023, at par value (the “4.875% Senior Notes”). On March 21, 2016, Cinemark USA, Inc. issued an additional $225.0 million aggregate principal amount of the 4.875% Senior Notes at 99.0% of the principal amount plus accrued and unpaid interest from December 1, 2015. These additional notes have identical terms, other than the issue date, the issue price and the first interest payment date, and constitute part of the same series as the Company’s existing 4.875% Senior Notes.  Interest on the 4.875% Senior Notes is payable on June 1 and December 1 of each year.  The 4.875% Senior Notes mature on June 1, 2023.  

The indenture to the 4.875% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of March 31, 2020, Cinemark USA, Inc. could have distributed up to approximately $3,367 million to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 4.875% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. Upon a change of control, as defined in the indenture governing the 4.875% Senior Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 4.875% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 4.875% Senior Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of March 31, 2020 was approximately 6.6 to 1.

Covenant Compliance

As of March 31, 2020, we believe we were in full compliance with all agreements, including all related covenants, governing our outstanding debt.

 

39


 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We have exposure to financial market risks, including changes in interest rates, foreign currency exchange rates and other relevant market prices.  

Interest Rate Risk

We are currently party to a variable rate debt facility.  An increase or decrease in interest rates would affect our interest expense relating to our variable rate debt. At March 31, 2020, we had an aggregate of approximately $143.5 million of variable rate debt outstanding.  Based on the interest rates in effect on the variable rate debt outstanding at March 31, 2020, a 100 basis point increase in market interest rates would increase our annual interest expense by approximately $1.4 million.

The table below provides information about our fixed rate and variable rate long-term debt agreements as of March 31, 2020:

 

 

 

Expected Maturity for the Twelve-Month Periods Ending March 31,

 

 

Average

 

 

 

(in millions)

 

 

Interest

 

 

 

2021

 

2022

 

2023

 

2024

 

2025

 

Thereafter

 

Total

 

 

Fair Value

 

 

Rate

 

Fixed rate

 

$

 

$

 

$

400.0

 

$

755.0

 

$

600.0

 

$

 

$

1,755.0

 

 

$

1,355.4

 

 

 

4.5

%

Variable rate (1)

 

 

6.6

 

 

6.6

 

 

105.4

 

 

6.6

 

 

18.3

 

 

 

 

143.5

 

 

 

135.5

 

 

 

3.0

%

Total debt

 

$

6.6

 

$

6.6

 

$

505.4

 

$

761.6

 

$

618.3

 

$

 

$

1,898.5

 

 

$

1,490.9

 

 

 

 

 

 

Interest Rate Swap Agreements

All of our interest rate swap agreements qualify for cash flow hedge accounting.  The fair values of the interest rate swaps are recorded on our consolidated balance sheet as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss.  See Note 7 to the condensed consolidated financial statements for further discussion of the interest rate swap agreements.

Foreign Currency Exchange Rate Risk

There have been no material changes in foreign currency exchange rate risk previously disclosed in “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K for the year ended December 31, 2019 filed February 21, 2020.

Item 4. Controls and Procedures

Evaluation of the Effectiveness of Disclosure Controls and Procedures

As of March 31, 2020, we carried out an evaluation required by the Exchange Act, under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of March 31, 2020, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and were effective to provide reasonable assurance that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 that occurred during the quarter ended March 31, 2020 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

40


 

PART II - OTHER INFORMATION

Other than the discussion at Note 19, there have been no material changes from legal proceedings previously reported under “Business – Legal Proceedings” in our Annual Report on Form 10-K for the year ended December 31, 2019 filed February 21, 2020.

Item 1A. Risk Factors

See discussion in “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019 filed February 21, 2020, as updated by the information related to COVID-19 that was included in a Form 8-K that was filed on April 13, 2020, including the documents incorporated by reference therein.

41


 

Item 6. Exhibits

 

 

 

 

*10.1

 

Sixth Amendment, dated as of March 31, 2020, to Indenture of Lease dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century Cinema 16, Mountain View, CA.

 

 

 

*10.2

 

Sixth Amendment, dated as of March 31, 2020, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 14, Folsom, CA.

 

 

 

*10.3

 

Sixth Amendment, dated as of March 31, 2020, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century Laguna 16, Elk Grove, CA.

 

 

 

*10.4

 

Seventh Amendment, dated as of March 31, 2020, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 16, Sacramento, CA.

 

 

 

*31.1

 

Certification of Mark Zoradi, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

*31.2

 

Certification of Sean Gamble, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

*32.1

 

Certification of Mark Zoradi, Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

*32.2

 

Certification of Sean Gamble, Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

* 101

 

The following material from Cinemark Holdings, Inc.’s Form 10-Q for the quarter ended March 31, 2020, formatted in iXBRL (Inline eXtensible Business Reporting Language), filed herewith: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Income (Loss), (iii) the Condensed Consolidated Statements of Comprehensive Income (Loss), (iv) the Condensed Consolidated Statements of Cash Flows and (v) the Notes to Condensed Consolidated Financial Statements.

 

 

 

* 104

 

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

*

filed herewith.

42


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

 

CINEMARK HOLDINGS, INC.

 

 

 

 

Registrant

 

 

 

 

 

DATE:

 

June 3, 2020

 

 

 

 

 

 

 

 

 

 

 

/s/ Mark Zoradi

 

 

 

 

Mark Zoradi

 

 

 

 

Chief Executive Officer

 

 

 

 

 

 

 

 

 

/s/ Sean Gamble

 

 

 

 

Sean Gamble

 

 

 

 

Chief Financial Officer

 

 

43